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Abstract
Background:  Worldwide, approximately two billion people are chronically infected with
Toxoplasma gondii with largely unknown consequences.
Methods: To better understand long-term effects and pathogenesis of this common, persistent
brain infection, mice were infected at a time in human years equivalent to early to mid adulthood
and studied 5–12 months later. Appearance, behavior, neurologic function and brain MRIs were
studied. Additional analyses of pathogenesis included: correlation of brain weight and neurologic
findings; histopathology focusing on brain regions; full genome microarrays; immunohistochemistry
characterizing inflammatory cells; determination of presence of tachyzoites and bradyzoites;
electron microscopy; and study of markers of inflammation in serum. Histopathology in genetically
resistant mice and cytokine and NRAMP knockout mice, effects of inoculation of isolated parasites,
and treatment with sulfadiazine or αPD1 ligand were studied.
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Results: Twelve months after infection, a time equivalent to middle to early elderly ages, mice had
behavioral and neurological deficits, and brain MRIs showed mild to moderate ventricular dilatation.
Lower brain weight correlated with greater magnitude of neurologic abnormalities and
inflammation. Full genome microarrays of brains reflected inflammation causing neuronal damage
(Gfap), effects on host cell protein processing (ubiquitin ligase), synapse remodeling (Complement
1q), and also increased expression of PD-1L (a ligand that allows persistent LCMV brain infection)
and CD 36 (a fatty acid translocase and oxidized LDL receptor that mediates innate immune
response to beta amyloid which is associated with pro-inflammation in Alzheimer's disease).
Immunostaining detected no inflammation around intra-neuronal cysts, practically no free
tachyzoites, and only rare bradyzoites. Nonetheless, there were perivascular, leptomeningeal
inflammatory cells, particularly contiguous to the aqueduct of Sylvius and hippocampus, CD4+ and
CD8+ T cells, and activated microglia in perivascular areas and brain parenchyma. Genetically
resistant, chronically infected mice had substantially less inflammation.
Conclusion: In outbred mice, chronic, adult acquired T. gondii infection causes neurologic and
behavioral abnormalities secondary to inflammation and loss of brain parenchyma. Perivascular
inflammation is prominent particularly contiguous to the aqueduct of Sylvius and hippocampus.
Even resistant mice have perivascular inflammation. This mouse model of chronic T. gondii infection
raises questions of whether persistence of this parasite in brain can cause inflammation or
neurodegeneration in genetically susceptible hosts.
Background
The protozoan parasite Toxoplasma gondii remains as a
chronic, cryptic, latent brain infection throughout the life
of the host [1]. Understanding the effects of chronic T.
gondii infection is particularly important because this par-
asite chronically infects 30–50% of the human popula-
tion worldwide [1]. There are a variety of reports that
suggest that chronic Toxoplasma  infection may alter
human behaviors, cognitive functions, and cause cryp-
togenic epilepsy, headaches, and onset of schizophrenia
[e.g., [2-4]]. In these studies, investigators have noted
increased seroprevalence for past T. gondii infection or
increased magnitude of antibody titers specific for T. gon-
dii in sera of persons with these medical problems [5].
Limitations of some of these studies have been discussed
[6]. None definitively prove a cause and effect relation-
ship [6].
At the same time, there have been a variety of often con-
tradictory reports of isolated and specific neurological
abnormalities in chronically infected, conventionally
housed (and thus possibly concomitantly infected), mice
or rats [7-15]. Some of these studies of prolonged T. gondii
infection in conventionally housed mice simply report
general neurological and behavioral abnormalities [7,8],
and others suggest there is a specific survival benefit to T.
gondii, by producing effects such as lack of fear and inabil-
ity to smell cat urine [9-16]. These are behaviors that
could imply that parasites specifically manipulate rodent
brains to render rodents more susceptible to capture by a
definitive feline host and thus to greater propagation by
highly infectious sporulated oocysts formed in and
excreted only by cats [12,15].
Earlier investigations of behavioral and neurologic findings
have not maintained and documented a specific pathogen
free (SPF) status of the mice or rats studied [7-16]. T. gondii
infection modulates both immune responses and out-
comes of many concomitant infections and tumors. The
outcome of T. gondii infection has been reported to be
modulated substantially by presence of either prior infec-
tions or concomitant infections [17-32]. Earlier studies
have attributed a variety of different findings to T. gondii
infection (e.g. congenital malformations) when the find-
ings were actually due to a virus contaminating the T. gondii
cultures [18,19]. In non-SPF mice, behavioral changes
ascribed to T. gondii infection may have been due to the
parasite itself, to a concomitant infection that causes neuro-
logic damage, to a concomitant infection modulating the
pathology that T. gondii causes, to T. gondii infection mod-
ulating the pathology a concomitant infection causes, or to
some combination of these.
In addition to the confounding factors of concomitant
infection, this parasite infects many animals in which
genetics of the host (between and within species) and par-
asite and their interactions determine different outcomes
of the primary acute acquired, reactivated chronic, and
congenital infection [33-41]. It has not been recognized
previously, however, that host genetics effect outcomes of
postnatally acquired infections with T. gondii that are
present for > 5 months or that resistant strains of mice
[36] chronically infected for prolonged times have neu-
ropathology.
There also are studies documenting that T. gondii modu-
lates a variety of functions in cultured human host cellsJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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(e.g., monocytes, fibroblasts, and retinal cells) [42-47]
and that this parasite increases expression of Human
Endogenous Retroviruses (HERVs) in a human neuronal
cell line [48]. The latter finding is similar to findings
reported in brain tissue from persons with schizophrenia
[49]. However, effects of chronic T. gondii infection on
transcriptomes and proteomes of brain or individual neu-
ronal cells from different regions of brain have not been
reported.
Furthermore, bradyzoites in cysts have been noted to fill
neuronal cells that nonetheless form synapses [50,51].
Recently, environmental conditions have been shown to
modulate neurotransmission at individual synapses [52],
but whether, and if so how T. gondii infection of neuronal
cells might alter neurotransmission remains to be deter-
mined.
Cyst burden or neuropathology has been reported in
some strains of mice infected for a month or two
[15,36,53]. However, one to two months following infec-
tion would still be considered an acute or subacute infec-
tion in humans [1,54].
None of the following have been previously reported
using mice infected for longer than 5 months: brain
weight and size, MRI studies, histopathology in specific
pathogen free mice infected with T. gondii, histopatho-
logic examinations at well-standardized times many
months after initiation of infection, pathology in various
regions of the brain, correlation of histopathology with
multiple neurological/behavioral tests, and whether path-
ologic changes observed could be due to concomitant
exposure to brain tissue initiating an autoimmune
response to brain rather than the parasite itself. Pathogen-
esis of neuropathologic changes and their distribution has
not been clarified for either acutely or chronically infected
mice.
The purpose of the studies herein is to begin to fill in these
current gaps in the literature and to provide a foundation
upon which questions regarding the effects of chronic T.
gondii infection, such as whether chronic infection could
play a role as a co-factor in some behavioral, neurological
or other neurodegenerative diseases in humans [55-61],
can be addressed.
Methods
Descriptions of mice and T. gondii infection of mice for 
behavioral and neurologic assessments, MRIs, microarrays, 
and histopathology
Swiss Webster mice
Female Swiss Webster (SW) mice were bred in our (RM)
laboratory and were derived from breeding pairs origi-
nally obtained from Harlan Laboratories (Indianapolis,
IN). These outbred females mice were between five and
seven weeks of age at the start of the experiments. Animals
were housed 5 or less/cage using an individually venti-
lated rack caging system from Allentown Caging Equip-
ment Company (Allentown, NJ). The Micro Barrier
System cages (Allentown Caging Equipment Company)
each had an internal area of 67 square inches (7.5 × 11.5
× 5 inches). The colony room was maintained at 22°C
with a 12–12 hour light/dark cycle (lights on at 600 h
CST). All animals were handled at least once/week for 10–
15 seconds. Food and water were available continuously
and the care and use of mice was in accordance with
AALAC and institutional guidelines. The colony was doc-
umented to be free of a large number of viral, bacterial,
and parasitic agents [62]. Specifically, testing for the path-
ogens listed below was performed monthly throughout
the studies of SW mice and all test results throughout the
studies were negative.
Viral pathogens
Mouse Hepatitis Virus (MHV); Coronavirus; Lymphocytic
Choriomeningitis Virus (LCMV); Minute Virus of Mice
(MVM); Mouse Encephalomyelitis Virus (GDVII); Reovirus-
2; Enteric Disease of Infant Mice (EDIM); K virus; Pneumonia
Virus of Mice (PVM); Ectromelia virus; Sendai virus; Polyoma
virus; Mouse Cytomegalovirus (MCMV); Mouse Adenovirus;
Hantaan Virus Mouse Thymic Virus (MTV)
Bacterial pathogens
Mycoplasma pulmonis; Salmonella spp.; Citrobacer rodentium;
Clostridium piliforme; Cilia Associated Respiratory (CAR)
Bacillus
Parasitic pathogens
Endoparasites; Pinworms (Syphaciasp, Aspiculuris tetraptera);
Tapeworms (Hymenolepis sp.); Protozoa (Giardia muris,
Encephalitozoon cuniculi); Ectoparasites; Mites (Myobia mus-
culi, Myocoptes musculinus Radfordia affinis, Psoregates sim-
plex)
Outbred mice used for electron microscopic studies were
maintained in non-SPF conditions in Glasgow, Scotland
(DF).
DBA mice used for the MRI (RK, J-HH) study were SPF
when obtained, and both controls and T. gondii infected
mice were housed in identical conditions in the same col-
ony at Albert Einstein College of Medicine where the MRI
facility available for this work was located. Age and strain
controls were matched for the MRI studies as for all other
studies in this manuscript.
Infection with T. gondii
For the studies described herein, Toxoplasma cysts of the
avirulent Me49 strain were obtained from the brains ofJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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female Swiss Webster mice that had been infected intra-
peritoneally (i.p.) between 6 and 16 weeks earlier. Brains
from the infected mice were homogenized in sterile saline
and an aliquot was used to count cysts. The suspension
was diluted in PBS pH 7.4 and 100 Me49 cysts were
administered i.p. into mice.
Experimental design/cohorts studied
A pilot experiment, to characterize and develop all the
behavioral and neurologic assessment measures, was per-
formed with mice infected with T. gondii when they were
1.5 or 7 months of age, and control mice. Behavioral and
neurologic evaluations were performed when they were
~12 months of age.
Then, an initial cohort of mice was studied systematically.
This cohort included 6 uninfected female SW, SPF control
mice and 10 female SW, SPF mice infected (as described
above) with T. gondii at ~1.5 months of age. The control
mice were age-matched to the infected mice and were
bred, born, and housed in the same colony. This cohort
was observed and behavioral and neurologic phenotypes
documented using all the behavioral and neurologic
assessments described in the methods section 11 to 16
months post infection with T. gondii.
In order to determine whether the results found in the
pilot and initial cohorts could be generalized, a subset of
the behavioral and neurologic measures were studied in
experiments in two additional studies continued over
time (called "kinetic replicate studies"). The two replicate
cohorts each included 5 control mice and 5 mice that were
infected at 7 months of age and a subset of assessments
were conducted monthly from 3 to 5 months post infec-
tion.
Descriptions of mice for histopathologic studies
Additional separate histopathologic studies and studies to
better understand pathogenic mechanisms (described
below) were performed with 1) SPF, female SW mice
infected with Me49 T. gondii as above or that were unin-
fected controls; 2) DBA, female SPF mice infected with
Me49 parasite without brain, and matched controls; 3)
the DBA mice for which MRIs were performed; 4) geneti-
cally resistant [36] SPF, female BALB/c mice that were
either uninfected controls or infected with Me49 T. gondii
as described above; 5) IL4 or IL6 or IL13 or NRAMP
knockout mice [63-66] that were infected with the Beverly
strain of T. gondii or uninfected controls.
Behavioral assessments
Assays for physical appearance and autonomic character-
istics, exploratory behavior, neuromuscular function and
sensorimotor function (described below) were developed
in a pilot study before being used to assess the initial and
additional cohorts described above. To conduct these
assays, mice were transferred from group housing to indi-
vidual home cages. After a thirty-minute period of habitu-
ation, animals were assessed using a series of well-
established ordinal scales [67,68] to categorize a broad
array of health and behavioral features as well as indices
of motor/neural function.
All measures were determined for the pilot and initial
cohort. Illness behavior, general appearance, activity, gait,
exploratory behavior, and sensorimotor function were
assessed in the additional, kinetic studies.
Physical appearance and autonomic characteristics
Illness behavior
Sick rodents often show characteristic hunched posture,
ruffled fur and a reluctance to move. Illness related behav-
iors and general appearance were assessed using the fol-
lowing scales:
Hunching
Healthy rodents often display a hunching posture during
periods of quiescence. Hunching was scored as (0)
absence of hunching; (1) presence of hunching.
Piloerection
Piloerection is a measure of autonomic instability and a
sign of distress. It was scored as (0) None; (2) Slight; (4)
Moderate; (6) Marked; (8) Extreme. This was analyzed as
absent = 0 or present = 1.
Grooming/Fur
Self-grooming and social grooming are ongoing behaviors
in mice and occur sporadically during the day. Sick or dis-
tressed animals often stop grooming, and their coats can
appear ruffled, yellow, gray and/or sticky. Grooming was
scored as (0) good; (1) sub-normal; (2) poor; or (3) very
poor. This was also analyzed as good = 0 or as not good =
1.
Palpebral closure
Palpebral closure is a measure of autonomic instability
and a sign of distress. It was scored as (0) normal, eyes
wide open; (2) 1/4 closed; (4) 1/2 closed; (6) 3/4 closed;
(8) completely closed. This was analyzed as normal = 0 or
as abnormal = 1.
Lacrimation
This was analyzed as absent = 0 or present = 1.
Salivation
This was scored as (0) None; (2) Very slightly wet; (4) Wet
zone 1/4 sub-maxilla area; (6) Wet zone 1/2 sub-maxillaJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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area; (8) Wet zone entire sub-maxilla area. This was ana-
lyzed as normal = 0 or abnormal = 1.
Urination/Defecation
Thought to be a measure of autonomic nervous system
tone, urination and/or defecation during brief periods of
handling were recorded.
Tail wounds
Presence of tail wounds or of severe shortening of tails,
highly atypical findings in rodents and salient in this
infected phenotype. This was analyzed as present = 1 or
absent = 0.
Body position/posture
Observations of vertical posture were made and body
position was recorded as a still photograph of each ani-
mal. Measurements of degree of body leaning were made
using the recorded image of each animal. This was ana-
lyzed as normal = 0 or abnormal body position (leaning)
= 1.
Body weight
Animals were weighed, often a sufficient measure of gen-
eral health, at the outset of the experiment and when
behavioral testing was complete.
Tremor
Tremors were scored on the following scale (0) None; (2)
Slight fine body tremor (1.5 mm); (4) Moderate coarse (3
mm) with slight impairment in locomotion; (6) Marked
coarse (4.5 mm) with moderate marked impairment; (8)
Extremely coarse (6 mm) with locomotion impossible.
Tremor was analyzed as present = 1 or absent = 0.
Activity
Mice were transferred from group housing to individual
home housing boxes. After a thirty-minute period of
habituation, animals were assessed using a series of well-
established ordinal scales to categorize a broad array of
health and behavioral features as well as indices of motor/
neural function [67,68].
Gait
This was scored as (0) normal gait and exploratory pat-
tern; (1–2) mild incoordination of gait; (3–7) moderate
incoordination; and (8–10) severe disability in moving
one or both hind legs with the higher number the most
severe. This was analyzed as normal = 0 or abnormal = 1
in the more extensive study.
Transfer arousal
Level of transfer arousal in the individual home cage was
assessed using a nine point scale: (0) Coma; (1) Marked
dulled; (2) Moderately dull; (3) Sub-alert; (4) Alert,
active; (5) Hyperalert; (6) Slightly excited; (7) Moderately
excited ("hypomania"); (8) Extremely Excited ('hyper-
manic'). Alert, active behavior was considered normal = 0
and other indicated behaviors as abnormal = 1.
Spatial locomotion
Level of spatial locomotion in the test cage was noted as
(0) none; (1) slow; (2) active. This was analyzed as active
= 0 or none/slow = 1.
Stereotyped behavior
Invariant and perseverating motor patterns included (a)
Wild running; (b) Constant circling; (c) Excessive groom-
ing; (d) Head bobbing; (e) Freezing. This was analyzed as
absence of stereotyped behavior = 0 and presence of any
stereotyped behavior = 1.
Exploratory behavior
Open-field testing
Mice were placed in a stainless steel field 40 cm × 40 cm ×
40 cm, consisting of 4 sides joined to form a square. The
box rested on a plastic platform on the floor; the floor of
the experimental field was covered with a single layer of
dark cage paper often used in animal cages. The only
object present in the field was a stainless steel bowl into
which the animal was gently placed at the beginning of
testing. In-room observers recorded latency (sec) to move
from the animal's initial position, and the number of
sniffs, rears, freezes and visits to the center of the field. The
open field study was a five minute timed exposure to the
open field.
Neuromuscular function
Grip strength
Each mouse was placed on the top of a standard wire cage
lid, the lid was shaken slightly allowing the mouse to grip
the wires; the lid was then gradually turned upside down.
The upside down lid was held approximately 20 cm above
soft padding, thus the mouse could not climb down but
was safe in the event of a fall. Investigators used a stop-
watch to measure latency to fall off the wire lid.
Vertical pole test
A metal pole, approximately 2 cm in diameter and 40 cm
long and wrapped with tape for improved traction was
autoclaved prior to testing. Each mouse was placed in the
center of the pole, which was held in a horizontal posi-
tion. The pole was then gradually lifted to a vertical posi-
tion. Deficits in motor coordination and balance were
detected when mice lost balance on the pole, usually
before the pole reached a 45° angle (See Movie, Addi-
tional file 1, online).
Sensorimotor function
Pain insensitivity
An autoclaved paper clip was placed at the base of the ani-
mal's tail to test pain sensitivity and sensorimotor integra-Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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tion. Latency to remove and/or attempt to remove the
paper clip was timed. Maximum trial length was thirty sec-
onds in the first experiment and sixty seconds in the next
two experiments.
MRI
T1 weighted and T2 weighted magnetic resonance imag-
ing was performed on a 9.4 Tesla imaging system (Varian
console) at the Albert Einstein School of Medicine. The T1
weighted gradient echo images were acquired to investi-
gate gray and white matter abnormalities using a multi-
slice inversion recovery gradient echo sequence. The T2
weighted images were acquired to highlight fluid using a
spin echo sequence with the following imaging parame-
ters: TR = 3 s, TE = 60 msec. Image resolution was 110 ×
110 microns in plane and 800 microns through plane
with 16 slices spanning from rhinal fissure to cerebellum.
Slice thickness was 1 mm. Six infected and 3 uninfected
age-matched control mice were imaged at 1 year of age.
Five of the infected mice had been infected for 8 months,
the pilot mouse had been infected for 1 year when
imaged. Ventricular size was measured using the histo-
gram feature in Adobe Photoshop to calculate the number
of pixels in a given area. The area (in pixels) of the ventri-
cles was divided by the area (in pixels) of the entire brain
in that frame for each mouse. The resulting ratio for each
mouse was compared using a two-tailed, two-sample t-
test.
Gene expression and statistical analysis of microarrays
The RNA from the brains of three SPF, SW mice infected
with T. gondii for a minimum of one year and three unin-
fected SPF, SW control mice bred and housed from birth
in the same colony were extracted using trizol (Invitrogen,
Carlsbad, CA). Brain was homogenized in saline (1 mL).
1 ml trizol was added to each sample of the cell pellets.
This was incubated at room temperature for 5 minutes.
Two hundred microliters of chloroform was added to each
sample. This was shaken vigorously for 15 seconds and
then incubated for 2 minutes at room temperature. This
was then centrifuged at 12000 g for 15 minutes at 4
degrees C. The aqueous phase was transferred to a fresh
tube and RNA was precipitated with .5 ml of isopropanol
per sample. Samples were incubated at room temperature
for 10 minutes and then centrifuged again at 12,000 g for
10 minutes at 4 degrees C. The gel like pellet of RNA was
washed with 1 ml of 75% ethanol per sample. The sample
was vortexed and re-centrifuged at 7500 g for 5 minutes at
4 degrees C. The ethanol was removed and the RNA pellet
was air-dried. The sample was resuspended in RNA free
water and quantitated using a spectrophotometer (260
lamba). The extinction coefficient aliquots of 40 μg (260/
280 was less than 1.6) were utilized for hybridization
experiments.
For hybridization experiments 40 μg total RNA was mixed
with a 17 mer dT oligo (Sigma) and reverse transcribed in
the presence of dNTPs containing 5-(3-aminoallyl)-
2'deoxyuridine-5'triophosphate, (aa-dUTP) (Sigma) with
SuperScript II® reverse transcriptase (Invitrogen) and con-
jugated to either Cy3 or Cy5 post-labeling reactive dyes
(GE Healthcare Biosciences) using a previously published
amino-allyl labeling technique [69-71]. Once re-sus-
pended in hybridization buffer, the labeled samples from
the three control and three infected mice were hybridized
in pairs to the mouse exonic evidence based oligo
(meebo) 36 K array. The MEEBO array is an open source
collection of probes designed to yield information on
~25,000 mouse genes. The collection includes probes for
~25,000 constitutive exons, ~4,000 alternately spliced
exons, and > 5,000 mRNAs. Further information can be
found at the web-links in the references section [72-74].
Specific details of the hybridization procedure can be
found using the web-link at reference [75].
Hybridized arrays were scanned with a dual-laser Axon
GenePix 4000A scanner (Axon Instruments) adjusting the
individual photo-multiplier tube (PMT) settings for each
channel according to manufacturers instructions. Spot
finding was done with BlueFuse 3.2 [76] which uses a
Bayesian approach where a single parametric model rep-
resents the microarray data generation process, including
sources of noise. The alignment of grids was checked prior
to spot finding, but no manual intervention or flagging
was performed. The BlueFuse output includes a single
measure of intensity for each channel, as well as a spot
quality measure (confidence), present call and quality
flag.
The data from BlueFuse were analyzed using R Version
2.2.0 for Windows [77], limmaGUI Version 1.4.0 [78]
and limma Version 2.3.3 [79] MA plots and M box plots,
generated with limmaGUI, showed that normalization
was required. Lowess normalization within print tips was
used to normalize the data within arrays, but between
arrays normalization was not required [80]. Using limma
the differences between experimental groups for each
gene were determined by specifying and estimating the
parameters of a linear model [81]. The significance of the
estimates was found from a moderated t-statistic based on
a global variance computed from all the genes using an
empirical Bayes approach. Several methods are available
for adjusting for multiple testing. In this analysis we con-
trolled the FDR (false discovery rate) to be less than 1%.
The posterior log-odds, B, that a gene is differentially
expressed was calculated and used to rank the genes.
The practice of excluding (filtering) poor quality spots
reduces power and efficiency and may lead to bias. Vari-
ous strategies for excluding or weighting spots using theJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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BlueFuse confidence measure and quality flag were com-
pared between two randomly chosen subsets of data cre-
ated from the 5858 genes which occur more than once on
the MEEBO array. Using the B statistic, the rank correla-
tion between the two subsets was calculated for each strat-
egy. The percentage of spots in the top N ranked genes
common to both subsets was calculated for all values of N
and plotted against N. Using these two criteria, weighting
poor quality spots by the square root or arcsine of the
BlueFuse confidence measure produced results that were
the most concordant between the two subsets. In the anal-
yses presented here all the spots corresponding to genes
were included in the analysis but were weighted by the
square root of the BlueFuse confidence measure.
Histopathology
Intact brains from SPF, SW mice were removed and placed
in paraformaldehyde overnight. Tissue was embedded in
paraffin; serial coronal sections (10 μm) were stained with
hematoxylin and eosin [82]. The presence of tissue cysts,
perivascular cuffing, and diffuse lymphocytic infiltrate
confirmed toxoplasmic encephalitis in infected mice.
Meningitis was scored 0 = none, 1 = mild, 2 = moderate,
3 = severe; Perivascular cuffing was scored 0 = none, 1 =
mild, 2 = moderate, 3 = severe; Inflammatory lesions were
scored according to the number identified in one section;
Calcifications were scored according to the number iden-
tified in one section; Cysts were scored according to the
number identified in one section; Inflammation with
cysts was scored as the number of cysts adjacent to inflam-
matory lesion – other cysts were in apparently normal
brain. There was no necrosis in any of the brains. Interpre-
tation of histopathology was performed by pathologists
(FR and RW) without knowledge of the infection status or
treatments of mice. Heart and aorta were also evaluated in
a subset of these mice.
Immunohistochemistry and electron microscopy
Immunostaining for T cells and activated microglia
Frozen tissue samples from SW mice that were part of the
same groups of mice used for behavioral, neurologic and
other histopathologic studies were prepared in 10 μm sec-
tions were fixed in 4% paraformaldehyde for 10 minutes
and washed with 4% PBS. Avidin/Biotin blocking solu-
tion (SP-2001, Vector Laboratories) and 3% hydrogen
peroxide (H325-500, Fisher Scientific) were used to block
endogenous enzyme activity. The tissue sections were
incubated with anti-mouse CD4 (1 μg/ml, GK1.5), CD8
(4 um/ml, Cat#553027 from PharMingen), CD11b (2–20
μg/ml MAB1458 from Chemicon International) antibod-
ies and biotinylated ricinus communis agglutinin I (10
ug/ml, B-1085, Vector Laboratories) at 4°C over night.
Biotinylated anti-mouse IgG (10 μg/ml, BA4001, Vector
Laboratories) was applied and incubated for 30 minutes.
Antigen-antibody binding was detected with an ABC kit
(PK-6100, Vector Laboratories) and DAB substrate chro-
mogen system (SK-4100, Vector Laboratories). Slides,
counterstained with hematoxylin, were evaluated using a
light microscope. Brain tissue from 5 control and 5
infected mice were compared.
Immunostaining for tachyzoites and bradyzoites and identification of 
host plasma cells
These studies were performed as previously described
[77]. Sections were double labeled with rabbit anti-SAG1
(tachyzoite specific) and mouse anti-BAG1 (bradyzoite
specific) and visualized using anti-rabbit-Ig conjugate to
fluorescein isothiocyanate and anti-mouse IG conjugated
to Texas red. In addition, the anti-mouse Ig also labeled
the immunoglobulins within the plasma cells thus identi-
fying their location. Additional sections were stained with
anti-SAG1 and antibody CC2 (stains tissue cyst wall).
Electron microscopy
The images of these sections were prepared as described
previously for the manuscript using non-SPF, SW mice
that were chronically infected with T. gondii [83]. They are
included herein to provide additional insights concerning
the pathogenesis of this infection in the context of the
immunostaining performed herein [50,51].
Myelin and other special neuronal staining and 
histopathology
Sections of the brains of SW mice that were part of the
other studies also were examined with hematoxylin and
eosin [82], trichrome, Bodian, Bielshowsky and Nissl
stains as well as with immunohistochemical stains for
neurofilament and amyloid precursor protein. Evidence
of neuronal loss, demyelination, axonal damage or wide-
spread microglial activation was sought using light micro-
scopy.
Lipoprotein and SAA analysis
To determine whether there was evidence of a systemic
inflammatory process altering plasma lipoproteins,
plasma lipoproteins in sera from the same SW mice that
were included in the behavioral and neurologic and his-
topathologic studies were separated by FPLC on tandem
Superose 6 columns and the cholesterol in the fractions
analyzed using a kit from Roche Molecular Diagnostics.
SAA in the plasma was determined by immunoblotting of
using a rabbit anti-mouse SAA antibody [84].
Knockout mice
To determine whether certain cytokines and innate
immune responses were necessary and sufficient for the
types of inflammatory responses observed in neuronal tis-
sues of the SW mice that formed the majority of the
present studies, mice without these cytokines or innate
immune responses, i.e., IL4, IL6, IL13, or Nramp knockoutJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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mice, in separate studies were infected, maintained and
studied as described previously [82]. Histopathology and
its analysis was performed exactly as above by one of the
same pathologists (FR) who evaluated the histopathology
of the SW mice. In these experiments, infection was with
the clonal type II Beverly strain of T. gondii.
Chronically infected and uninfected control Balb/c mice
Chronically infected and uninfected control Balb/c mice
were maintained in a SPF colony in our (YS) laboratory
[85]. The mice were either infected with Me49 T. gondii or
were uninfected controls and were processed for histopa-
thology as described above and evaluated by pathologists
including one of those (RW) who characterized pathology
in the SW mice without knowledge of the infection status
or treatment of the mice. Brain tissue was obtained at 2
and 5–6 months following initiation of infection.
Treatment of mice with sulfadiazine
To determine whether tachyzoites contributed to the
inflammatory process observed, mice that had been
infected for 5 months were treated with sulfadiazine (100
mg/ml) in their drinking water for 4 months. This treat-
ment is known to eliminate tachyzoites from brain but
not to eliminate cysts (McLeod, Unpublished data).
Treatment of mice with hamster polyclonal antibody to 
PD-L1 or hamster isotype-control
This was administered as described [86] and as had been
shown in earlier studies to ablate PD-L1 function in mice.
Statistical analysis of behavioral and neurologic findings
Statistical analysis was conducted using Stata Version 9
(Stata Corp., College Station, TX). Cognitive/behavioral
assessments were summarized as mean ± SD unless other-
wise noted. For comparisons between infected/uninfected
mice, the Wilcoxon rank-sum test, Kruskal-Wallis test, or
Fisher's exact test, was used as appropriate. An overall
behavioral measure was created using the total number of
behaviors exhibited. For those behaviors that had a con-
tinuous distribution (e.g., latency to move), the median
value was used as the cutoff for creating a dichotomous
variable. Additionally, some ordinal scales were dichot-
omized (i.e., absent = 0 or present = 1).
Statistical analysis of histopathologic findings
Statistical analysis was conducted using Stata Version 9
(Stata Corp., College Station, TX). Histopathological data
were summarized as mean ± SD unless otherwise noted.
For comparisons between infected/uninfected or treated/
untreated mice, the Wilcoxon rank-sum test, Kruskal-Wal-
lis test, or Fisher's exact test, was used as appropriate.
Spearman rank correlation coefficients (r) were calculated
when examining the associations between pathological
findings and behavioral measures. An overall measure of
disease burden based on the pathological findings was
created by taking the sum across types of findings (cuffing,
inflammation, calcifications, cysts, and inflammation
with cysts) and brain regions (Co, D, H, and Ce). Fried-
man's test, a nonparametric alternative to the repeated
measures analysis of variance (ANOVA), was used for
comparisons between brain regions among infected mice
only. The pathological findings in the four areas of the
brain were considered after summing across types of find-
ings.
Results
Appearance, behavior, and neurological findings in the 
initial cohort
Decrements in behavioral and neurological function in
infected mice were first observed in a pilot study and then
systematically characterized for all assessments in the "ini-
tial cohort" (Table 1; Figures 1, 2; movie – Additional file
1). These results were observed in carefully monitored and
characterized SPF mice chronically infected with T. gondii.
Standard measures of appearance (grooming, body posi-
tion, piloerection, tail wounding, gait, tremor, and
weight), behavior (exploration, freezing, and rearing),
and neurologic function (grip strength, motor coordina-
tion and balance, and pain sensitivity) were assessed.
Abnormalities were noted in the pilot experiment at 5 and
11 months after infection and in the initial cohort at 11 to
16 months after infection.
In Figure 1, the normal, sleek appearance of the unin-
fected control mouse (Figure 1A) contrasts with the ruf-
fled fur and tail wound of the infected mouse in Figure 1B
and the tilted posture of the infected mouse in Figure 1C.
The number of mice with abnormal findings in various
aspects of their appearance are shown in Figure 2A. With
the exception of stereotyped behavior, palpebral closure,
lacrimation, and salivation, the difference between
infected and uninfected mice in all of the categories
(grooming, body position, piloerection, tail wounds, and
tremor) was statistically significant (Table 1, Figure 2A).
In this initial cohort, chronically infected mice weighed
less than uninfected mice at both 11 and 16 months after
infection (Figure 2B; p = 0.04, p = 0.007). In addition, the
infected mice lost weight over time while the uninfected
mice gained weight. Locomotion including transfer
arousal and gait were both significantly different in
infected mice than in uninfected mice (Table 1; p = 0.035,
p = 0.034). A decrease in autonomic nervous system func-
tion of infected mice, measured by increased urination
and defecation during brief periods of handling, was also
statistically significant when compared to uninfected mice
(Table 1; p < 0.001). Exploratory movements including
sniffs, rears, movement to the center of an open field were
significantly less and latency to move significantly greaterJ
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Table 1: Neurologic and behavioral findings in SPF SW female mice infected at 7 months of age and tested at 12 months of age
APPEARANCE LOCOMOTION ANS OPEN FIELD ACTIVITY
Condition Grooming Body 
Position
Piloerection Tail 
Damage
Tremor Palpebral 
Closure
Lacrimation Weight 
(gm)
Spatial 
Locomotion
Gait Urination/
Defecation
Sniffs Rears Center Freezing Latency to 
move (sec)
Control Good - - - - - - 39.4 Active - - 2 20 4 0 4
Control Good - - - - - - 52.3 Active - - 4 4 2 0 22
Control Good - - - - - - 45.0 Active - - 6 13 3 0 41
Control Good - - - - - - 50.5 Active - - 1 0 7 0 120
Control Good - - - - - - 50.6 Active - - 4 9 7 0 10
Control Good - - - - - - 58.5 Active - - 1 2 9 0 1
Infected Poor + + + + - - 43.8 Slow + + nd nd nd nd nd
Infected Good + + + - - - 41.2 Active + + 0 0 0 0 180
Infected Very Poor + - + + - - 42.0 None + + 0 0 0 0 180
Infected Very Poor + + - + + + 35.3 None + + nd nd nd nd nd
Infected Good - + + - - - 34.9 Active - + 0 0 0 0 180
Infected Very Poor + + - + + + 34.8 Slow + + 0 0 0 0 180
Infected Poor + + + + + + 35.6 Slow + + 1 3 1 1 24
Infected Sub-
normal
+ + - + + + 36.2 Active - + 0 2 10 1 6
Infected Very Poor + + + - - + 58.0 None - + 0 0 0 0 180
Infected Poor + + + + - - 54.2 Slow - + 2 0 1 2 56
P-values 0.018 0.001 0.001 0.011 0.011 0.23 0.093 0.059 0.035 0.034 < 0.001 0.0055 0.016 0.017 0.11 0.021
+ = abnormal, - = normal, nd = not done. Figure 1 shows representative examples of abnormal grooming, body position, piloerection, and tail damage (Figure 1 B, C) in infected mice when compared 
with control shown in Figure 1A.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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in infected mice (Figure 2C; p = 0.0055, p = 0.016, p =
0.017, p = 0.021) and only infected mice exhibited freez-
ing behavior, although it did not achieve statistical signif-
icance.
Measures of motor and sensorimotor function also were
impaired in infected mice (Figure 2D). Infected mice dis-
played a statistically significant increase in the time it took
to remove/attempt to remove a paperclip attached to their
tail (indicating decreased pain sensitivity as a sensorimo-
tor measure; p = 0.003) and a statistically significant
decrease in the length of time that both grip strength and
balance were maintained (p = 0.005; p = 0.01; please also
see Movie, Additional file 1 in on-line supplement).
Kinetics of development of behavioral and neurologic 
abnormalities in two additional studies (replicates of each 
other)
To characterize the kinetics of development of these find-
ings and to make certain a subset of our initial observa-
tions were reproducible, two additional experiments with
5 infected mice and 5 control mice in each experiment
were performed. In these replicate studies, appearance,
gait, exploratory behavior, and pain sensitivity (paperclip
test) were evaluated. In both of the replicate experiments,
abnormalities in appearance, similar to those found in the
initial cohort, were found in some of the infected mice as
early as 3 months post infection, the initial time observa-
tions were made. By 5 months after infection, four of the
ten infected mice in the combined replicate studies had
died, two had pronounced gait abnormalities involving
their lower extremities, and all but one of the remaining
mice had more subtle abnormalities in gait. These latter
mice moved their lower extremities more slowly and less
facilely and had diminished exploratory behavior when
placed in a novel, open environment. One of the three
mice with the subtler gait abnormalities had a posture
where it was tilted to one side. At the time of the initial
observations (3 months post infection), infected mice
were taking longer, on average, to notice the paper clip
attached to their tail, although this did not reach statistical
significance (14.9 ± 13.0 vs. 6.4 ± 8.7 seconds in controls,
p = 0.39). At five months, the difference was larger and
statistically significant (20.5 ± 11.1 vs. 8.4 ± 7.0 seconds,
p = 0.039). No tail lesions, which were noted in the initial
cohort, were seen in any of these ten mice before the
experiment was terminated.
Brain MRIs of chronically infected mice have mild to 
moderate ventricular dilatation
To determine whether noninvasive neuroimaging could
identify any abnormalities and if so their anatomic distri-
bution, brain MRIs were performed for 6 chronically
infected mice (8 months after infection [n = 5] or 12
months after infection in the case of the pilot [n = 1]) and
3 control mice. Representative frames from the MRIs are
in Figure 3. T1 weighted images showed no clear abnor-
malities between the uninfected and infected mice. T2
weighted images (Figure 3) for the control, uninfected
mice revealed no abnormalities other than very slight lat-
eral ventricular dilatation. Similar MRI images of the
brains of the infected mice, however, showed no (n = 1),
mild (n = 1) and moderate (n = 4) lateral ventricular dila-
tation, which can be seen in the lateral ventricles approx-
imately 0 to 1 mm caudal to bregma when compared to
the MRIs from the uninfected mice. Quantitation of the
differences in ventricular size at approximately 1 mm cau-
dal to bregma revealed smaller ventricles in the uninfected
as compared with the infected mice, which was statisti-
cally significant (p = 0.03). In addition, the areas adjacent
to the aqueduct of Sylvius had enlargement of the ventri-
cles and periventricular and periaqueductal changes (Fig-
ure 3). At approximately 6 mm caudal to bregma, the
difference in ventricular size between the uninfected and
infected mice also was statistically significant (p = 0.002).
No parenchymal abnormalities were noted in two of the
infected mice, and asymmetry of uptake of contrast in the
Appearance of eleven-month-old Specific Pathogen Free (SPF) mice that are uninfected and chronically infected with T. gondii Figure 1
Appearance of eleven-month-old Specific Pathogen Free (SPF) mice that are uninfected and chronically 
infected with T. gondii. (A) Eleven month old uninfected Swiss Webster mouse. (B) Eleven month old infected female mouse 
from the same SPF colony ten months after acquisition of T. gondii infection. Note hunched body position, poor grooming, pilo-
erection, reduced body mass, and tail wounding. (C) Chronically infected SPF mouse with abnormal body position.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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Behavioral and Neurologic Data of eleven-month-old Specific Pathogen Free (SPF) mice that are uninfected and chronically  infected with T. gondii Figure 2
Behavioral and Neurologic Data of eleven-month-old Specific Pathogen Free (SPF) mice that are uninfected 
and chronically infected with T. gondii. (A) Number of mice with abnormal behavior or neurologic findings. (B) Weight of 
uninfected and chronically infected mice at eleven (p = 0.04) and sixteen months (p = 0.007) after infection. Error bars indicate 
one standard error. (C) Exploratory behaviors in mice twelve months after infection. Error bars indicate one standard error. 
(D) Motor and sensorimotor function in uninfected and infected mice eleven to sixteen months after infection. Error bars indi-
cate one standard error. n = 6 control; n = 10 infected in all cases.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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MRI findings in chronically infected mice and in uninfected mice Figure 3
MRI findings in chronically infected mice and in uninfected mice. T2 weighted MRIs from uninfected mice (U1-3), 
chronically infected mice (I1-5), and one infected mouse studied in a pilot experiment at a different time (P1). MRIs were 
obtained when mice were 1 year old and infected mice had been infected for 8 months. In infected mice there was minimal to 
moderate ventricular dilation. Images from the Allen Brain Atlas are provided in the top panel for reference to the brain region 
imaged. Lateral ventricles are marked with a circle and the 3rd ventricle/aqueduct of Sylvius is marked with a square. Unless 
otherwise noted, the 4th ventricle is marked with an arrow. T2 weighted MRI of the brain in infected and age-matched control 
mice show an increase of size in the lateral ventricle of infected mice (p = 0.034 approximately 1.155 mm caudal to bregma) 
and an increase in 3rd ventricle size (marked by a square) of infected mice (far right panel, p = 0.002). In 4 of 6 infected mice 
there is right-left brain asymmetry (I1, I3, I4, I5). The major difference between the infected and the uninfected MRIs was ven-
tricular dilatation and some asymmetry present in brain parenchyma of infected mice.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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cortex in the T2 weighted images was noted in the other
four infected mice.
Correlation of brain weight and neurologic findings
Studies of brain weight and correlation with behavioral
and neurologic studies were performed to examine
whether chronic T. gondii causes loss of brain parenchyma
and neuronal cells and whether behavioral and neuro-
logic abnormalities correlated. Such neuronal cell loss was
suggested by the brain MRI studies and the increase of
GFAP message in the full genome microarrays which
reflected neuronal cell injury (see below). In the first
behavioral and neurologic experiment, brain weight was
not measured. In the second and third replicate experi-
ments described earlier, the mean ± sd [range] of brain
weight for infected and control groups were 0.42 ± 0.04
[.385–.466] g and 0.46 ± 0.03 [0.427–0.510] g, respec-
tively (p = 0.065). Further, the infected mice that had
more obvious gait abnormalities had the smallest brains.
In these experiments a score for abnormal neurologic
function and movement pattern was defined as follows:
normal gait and exploratory pattern was scored as 0, mild
incoordination of gait was scored a 1 or 2, moderate inco-
ordination was scored 3–7 and severe disability in moving
one or both hind legs was scored 8–10, with the higher
number the most severe. All of the uninfected mice had a
score of 0. The uninfected mice quickly moved from the
center of the open field to the perimeter usually moving
around the perimeter in one direction exploring it. There
were no neurologic abnormalities and no association of
body size with brain weight present in the 10 uninfected
mice (r = -0.024, 95% CI (-0.64, 0.62), p = 0.95). In con-
trast, all but one of the infected mice moved much less
and had a less organized movement pattern around the
perimeter of the testing area, with greater severity of that
pattern associated with abnormal movement of the hind
extremities. The correlation coefficient for the association
of abnormal neurologic examination and movement pat-
tern (i.e., higher score as described above) with dimin-
ished brain weight in infected mice was -0.53 (95% CI (-
0.81, -0.05), p = 0.035).
Microarrays reflect inflammation and increased 
expression of CD36 and PD1L, GFAP, ubiquitin ligase, and 
C1q
To determine molecular mechanisms whereby T. gondii
alters brain cell functions and reflects the pathogenic
process, full genome microarrays were performed using
the MEEBO array containing ~36000 probes representing
~25000 genes. All the probes that were significantly differ-
entially expressed are summarized and listed individually
in Table 2. There were 326 significant probes (correspond-
ing to 311 different genes) with an adjusted P-value less
than 0.01 and a posterior log odds of differential gene
expression greater than 2 (i.e. a posterior probability
greater than 0.88). All these genes showed greater expres-
sion in the chronically infected brains and many are asso-
ciated with the immune response (Table 2[87,88]). There
were no significantly downregulated genes. The microar-
ray results are consistent with an inflammatory process
involving immunoglobulin and B cells and interferon
gamma production. In addition, there was increased
expression of the Suppression of Cytokine Signaling
(SOCS), CD36, and PD-1L genes and others including
C1q. GFAP expression reflects astrocyte response to neu-
ronal cell injury. Ubiquitin ligase expression is increased,
likely reflecting effects on host cell protein processing.
Histopathologic abnormalities and immunohistochemistry
To better understand the pathologic processes that caused
the abnormal behavior and neurologic function described
earlier, histopathology of brain and special immuohisto-
chemistry studies focusing on anatomic brain regions also
were performed. Consistent with some of the earlier stud-
ies of non-SPF mice [7], histopathological analyses
revealed brain abnormalities in the infected SPF mice
(Figure 4A–D). These findings included mild to moderate
diffuse parenchymal infiltrates of inflammatory cells (pre-
dominantly lymphocytes) and with the appearance of
microglia (Figure 4A–D). Collections of lymphocytes and
plasma cells appeared around blood vessels of different
sizes and in the leptomeninges (Figure 4C, D). Focal cal-
cifications were also observed, suggesting a previously
healed inflammatory process. Our pathological findings
in the context of this chronic infection included rare
encysted bradyzoites, the parasite's latent life stage (Figure
4, Table 3). Cysts located within neurons were not associ-
ated with an inflammatory response (Figure 4A arrow).
Solitary cysts in the brain parenchyma usually were
remote from inflammation and calcifications but were
occasionally adjacent to, but separate from, perivascular
and intra-parenchymal inflammation (Figures 4A arrow).
In the brain, CD4+ T cells, CD8+ T cells, plasmacytoid B
cells, and activated microglial cells formed prominent
perivascular infiltrates (cuffs around vessels of all sizes)
(Figures 4E–F and 5) and diffuse parenchymal infiltrates
(Figure 5) which were not present in micrographs of tis-
sues concomitantly prepared from control mice. In chron-
ically infected mice, the individual plasma cells around
vessels were identified by the presence of the immu-
noglobulin within the cytoplasm (Figures 4E, F). In our
chronically infected, SPF mice there were rare microglial
nodules but no areas of necrosis as seen in immune-com-
promised persons [89], mice with the C57BL/6J genetic
background [36], or various other murine models of
immune-deficiencies. In sharp contrast to areas of necro-
sis in genetically susceptible rodents and immune-com-
promised persons, manifestations of the infection weJ
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Table 2: Genes upregulated in the brains of mice infected with T. gondii for a year
Function Gene* [Number/ID]†
Antibody Ig heavy chain V regions [116] 
Ig kappa V regions [119] 
Ig lambda 1 germline V region (Igl-V1, 1810027O01Rik, IgL) [V00811]
Ig alpha chain (IGHV1S44) [M19402]
Rearranged IgA-chain gene, V region (IGHV1S46) [M20774]
IgG-1 gene, D-J-C region: 3' exon for secreted form (Igh-4, IgG1) [J00453]
Ig germline D-J-C region alpha gene and secreted tail (Igh-VJ558, AI893585, MGC118142, MGC6727, Igh-A (1g2), Vh186.2/Jh2) [J00475]
Ig gamma2a-b(c57bl/6 allele) c gene and secreted tail (IGHG2C) [J00479]
Immunoglobulin joining chain (Igj, 9530090F24Rik, AI323815, Jch) [NM_152839]
Antigen presentation MHC-I Similar to H-2 MHC-I antigen, D-37 alpha chain precursor (C920025E04Rik) [AK083387]
MHC-I Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) (Tap2, ABC18, AI462429, APT2, Abcb3, Ham-2, Ham2, MTP2, PSF2, RING11, Tap-2, Y1, 
jas) [NM_011530]
MHC-II [22]
MHC-III (D17H6S56E-3, C6orf27, G7c, NG37) [NM_138582]
Beta-2 microglobulin (B2m, Ly-m11, beta2-m) [NM_009735]
Complement Complement component 4A/sex limited protein (C4a, Slp)
GeneCards: Primarily expressed in liver and to a lesser extent in immune cells [NM_011413]
Complement component 4B (C4b, C4, Ss) [NM_009780]
Complement component 1, r subcomponent (C1r, AI132558, C1rb) [NM_023143]
Complement component C1SB (C1sb) [NM_173864]
Complement component 1, q subcomponent, alpha polypeptide (C1qa, AI255395, C1q) [NM_007572]
Complement component 1, q subcomponent, C chain (C1qc, AI385742, C1qg, Ciqc) [NM_007574]J
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Major inhibitor of classical 
complement
Serine (or cysteine) peptidase inhibitor, clade G, member 1 (Serping1, C1INH, C1nh) [NM_009776]
Serine (or cysteine) peptidase inhibitor, clade A, member 3N (Serpina3n, Spi2-2, Spi2.2, Spi2/eb.4)
GeneCards: Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase. [NM_009252]
GTPase Interferon inducible GTPase 1 (Iigp1, 2900074L10Rik, AI046432, AW111922, Iigp) [AK013785]
Interferon inducible GTPase 1 (AW111922, Iigp1) [NM_021792]
Interferon inducible GTPase 2 (Iigp2, RP24-499A8.1, AI481100, GTPI, (GC102455) [NM_019440]
Interferon gamma inducible protein 47 (Ifi47, IRG-47, Iigp4, Iipg4, Olfr56) [NM_008330]
Interferon gamma induced GTPase (Igtp, RP24-499A8.4, AW558444) [NM_018738]
GTPase, IMAP family member 4 (Ian1, Gimap4, AU019574, E430007K16Rik, IMAP4, MGC11734, mIAN1), transcript variant 1
GeneCards: Exhibits intrisinic GTPase activity. [NM_174990]
Transcription Signal transducer and activator of transcription (Stat1, 2010005J02Rik, AA408197)
GeneCards: Mediates signaling by interferons. Results in induction of a cellular antiviral state. [NM_009283 BC057690]
Transcription factor MafB (v-maf musculoaponeurotic fibrosarcoma oncogene homolog B).(Mafb, Kreisler, Krml, kr)
GeneCards: Plays a pivotal role in regulating lineage-specific hematopoiesis by repressing ETS1-mediated transcription of erythroid-specific genes in myeloid 
cells (By similarity). [NM_010658]
Down regulator of transcription 1/Differentially regulated in lymphoid organs and differentiation (Dr1d) [AF043513]
Suppression of cytokine signaling Suppressor of cytokine signaling 1 (Socs1, Cish1, Cish7, JAB, SOCS-1, SSI-1)
GeneCards: SOCS1 is involved in negative regulation of cytokines that signal through the JAK/STAT3 pathway. Appears to be a major regulator of signaling 
by interleukin 6 (IL6) and leukemia inhibitory factor (LIF). Regulates interferon-gamma mediated sensory neuron survival (By similarity). [NM_009896]
Proteosome/antigen processing Proteosome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7)
(Psmb8, Lmp-7, Lmp7) GeneCards: This subunit is involved in antigen processing to generate class I binding peptides.
Stimulated by interferon gamma, involved in the degradation of cytoplasmic antigens for MHC class I antigen presentation pathways. [NM_010724]
Proteosome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) (Psmb9, Lmp-2, Lmp2) GeneCards: stimulated by interferon 
gamma, involved in the degradation of cytoplasmic antigens for MHC class I antigen presentation pathways. [NM_013585]
Proteasome (prosome, macropain) 28 subunit, alpha (Psme1, AW413925, MGC113815, PA28a)
GeneCards: Implicated in immunoproteasome assembly and required for efficient antigen processing. The PA28 activator complex enhances the generation 
of class I binding peptides by altering the cleavage pattern of the proteasome. Induction by interferon gamma. [NM_011189]
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Antimicrobial Secretory leukocyte peptidase inhibitor (Slpi)
Acid-stable proteinase inhibitor with strong affinities for trypsin, chymotrypsin, elastase, and cathepsin G. Secretory leukoprotease inhibitor, involved in 
antineutrophil elastase protection at inflammatory sites. [NM_011414]
Defensin related cryptdin 17 (Defcr17, AU014719, Cryp17)
GeneCards: Acid-stable proteinase inhibitor with strong affinities for trypsin, chymotrypsin, elastase, and cathepsin G. Secretory leukoprotease inhibitor, 
involved in antineutrophil elastase protection at inflammatory sites [S73391]
Pre-B-cell growth Bone marrow stromal cell antigen 2 (Bst2, 2310015I10Rik, C87040, DAMP-1)
GeneCards: May be involved in pre-B-cell growth. [NM_198095]
T lymphocyte proliferation CD274 antigen/Programmed cell death 1 ligand 1 precursor (Cd274, B7-H1, PD-L1, Pdcd1l1, Pdcd1lg1)
Genecards: Involved in costimulatory signal, essential for T lymphocyte proliferation and production of IL10 and IFNG, in an IL2-dependent and a PDCD1-
independent manner. Interaction with PDCD1 inhibits T-cell proliferation and cytokine production. Up-regulated on T and B cells, dendritic cells, 
keratinocytes and monocytes after LPS and IFNG activation. Up-regulated in B cells activated by surface Ig cross-linking. [NM_021893]
Lymphocyte activation Lymphocyte-activation gene 3 (Lag3, CD223, LAG-3, Ly66)
GeneCards: Involved in lymphocyte activation. Binds to HLA class-II antigens. Highly homologous to CD4, expressed exclusively in activated T and NK 
lymphocytes, major MHC class 2 ligand potentially involved in the regulation of immune response. [NM_008479]
Macrophage growth Guanylate nucleotide binding protein 2 (Gbp2)
Uniprot: Interferon-induced Gbp 2 [NM_010260]
Guanylate nucleotide binding protein 4 (Gbp4, AW228655, Gbp3) [NM_018734]
Macrophage activation 2/guanylate-binding protein 4 homolog (Mpa2, AW228052, Gbp4, KIAA4245, Mag-2, Mpa-2, mKIAA4245) [NM_008620]
Macrophage activation 2 like (MPA2l, AI595338) [NM_194336]
Guanylate nucleotide binding protein 5 (Gbp5, 5330409J06Rik) Uniprot: Interferon-induced Gbp5 [NM_153564]
RIKEN cDNA 5830443L24 gene/guanylate binding protein 8(5830443L24Rik, mGBP8) [NM_029509]
cDNA sequence BC057170/guanylate binding protein like (BC057170, E430029F06) [NM_172777]
Immune response/binding Interferon-induced protein with tetratricopeptide repeats 3 (Ifit3, Ifi49, MGC107331) [NM_010501]
GO:0000004 biological process unknown
GO:0005488 binding
GO:0005554 molecular function unknown
GO:0006955 immune response
GO:0008372 cellular component unknown
Astrocyte protein after trauma Glial fibrillary acidic protein (Gfap, AI836096)
GeneCards: Class-III intermediate filament, cell-specific marker; during development of CNS distinguishes astrocytes from other glial cells. Almost exclusively 
expressed in astrocytes; interacts with S100A1.
S100A1 home page: S100A1 and S100B can be isolated as a complex from bovine brain; mixture of S100A1 and S100B inhibited the assembly of tubulin into 
microtubules [NM_010277]
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Chemo-attractants Chemokine (C-C motif) ligand 5 (Ccl5, MuRantes, RANTES, SISd, Scya5, TCP228) GeneCards: Chemoattractant for blood monocytes, memory T helper cells 
and eosinophils. [NM_013653]
Chemokine (C-C motif) ligand 8/monocyte chemoattractant protein-2 precursor (Ccl8, RP23-446K18.1, 1810063B20Rik, AB023418, HC14, MCP-2, Mcp2, 
Scya8)
GeneCards: Interferon gamma induced chemotaxis Attracts monocytes, lymphocytes, basophils, eosinophils [NM_021443]
Cell adhesion/interaction CD36 antigen/fatty acid translocase (Cd36, FAT, GPIV, Scarb3)
May function as a cell adhesion molecule. GeneCards: Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Mediates free 
radical production in cerebral ischemia.
Publication (Khoury, J Exp Med 2003, 197(12) 1657–1666): CD36, a major pattern recognition receptor, mediates microglial and macrophage response to 
beta-amyloid, and imply that CD36 plays a key role in the proinflammatory events associated with Alzheimer's disease. [NM_007643]
EGF-like module containing, mucin-like, hormone receptor-like sequence 1/cell surface glycoprotein F4/80/lymphocyte antigen 71 (Emr1, D7A5-7, EGF-TM7, 
F4/80, Gpf480, Ly71, TM7LN3)
GeneCards: Could be involved in cell-cell interactions. [NM_010130]
Lectin, galactoside-binding, soluble, 3 binding protein/cyclophilin associated. protein (Lgals3bp, 90K, CyCAP, MAC-2BP, Ppicap)
GeneCards: Promotes integrin-mediated cell adhesion. May stimulate host defense against viruses and tumor cells. [NM_011150]
Leukocyte integrin/actin signaling FYN binding protein (Fyb, ADAP, B630013F22Rik)
GeneCards: Acts as an adapter protein of the FYN and SH2-domain-containing leukocyte protein-76 (SLP76) signaling cascades in T cells. Modulates 
expression of interleukin-2 (IL-2). [NM_011815]
Free radical production Cytochrome b-245, beta polypeptide (Cybb, C88302, Cgd, Nox2, gp91<phox>, gp91phox) GeneCards: Critical component of the membrane-bound oxidase of 
phagocytes that generates superoxide. [NM_007807]
Apoptosis retardation B-cell leukemia/lymphoma 2 related protein A1c(Bcl2a1, A1-c c)
GeneCards: Retards apoptosis induced by IL-3 deprivation. May function in response of hemopoietic cells to external signals and in maintaining endothelial 
survival during infection (By similarity). [NM_007535]
ADP ribosylation Poly (ADP-ribose) polymerase family, member 14/collaborator of STAT6 (Parp14, 1600029O10Rik, BC021340, KIAA1268, MGC29390, mKIAA1268) 
[BC021340]
Unknown [XM_207778]
* Gene names and symbols from Entrez Gene [87] and function information from GeneCards [88]
†Either the number of genes in this category or the accession number
Function of all genes significantly upregulated in the brains of mice infected with T. gondii for a year (p-value after adjustment for multiple testing < 0.01). No genes were significantly 
downregulated. Gene names and symbols were retrieved from Entrez Gene [87] using the accession number and function information from GeneCards [88]. Each distinct gene symbol is included 
in the column headed Gene, except for the functions Antibody and Antibody presentation, where there were too many similar accession numbers. The Number/ID is in brackets contains the 
accession number where there were < 4 for a function or else a count of the accession numbers for that function.
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observed are associated with substantial chronic inflam-
matory processes without extracellular organisms.
Sections of brains from chronically infected animals and
controls also were studied with trichrome, Bodian,
Bielshowsky, Luxol blue, and Nissl stains as well as with
immunohistochemical stains for neurofilament and amy-
loid precursor protein to examine for evidence of neuro-
nal loss, demyelination, axonal damage or widespread
microglial activation. However, while the brains of chron-
ically infected mice were smaller than controls, despite the
presence of focal areas of chronic inflammation, it was not
possible to demonstrate neuronal loss, axonal injury nor
extensive demyelination.
As also demonstrated by Ferguson et al in separate studies
[50,51], immunostaining only very rarely identified
bradyzoites outside cysts (Figure 4G) and only one tach-
yzoite was identified in all the sections examined from
many mice (Figure 4H). However, this confirmed the
technique was suitable for the identification of even low
numbers of tachyzoites and bradyzoites. (Figures 4E, F).
The presence of very few extracellular parasites contrasted
with the robust immune response in the brain paren-
chyma, leptomeninges and around blood vessels.
Anatomic distribution of lesions and parasite burden 
demonstrate different areas of predominance of cysts and 
calcifications
To better understand the basis for the broad range of
behavioral and neurologic abnormalities observed, distri-
bution of lesions and parasite burden in various anatomic
areas was characterized (Tables 3, 4, 5 and 6). Inflamma-
tion and parasite burden were greatest in diencephalon
(mean ± SD, median, range: 6.4 ± 3.9, 6, 1–13), then cor-
tex (5.6 ± 3.2, 4.5, 2–12), and then hippocampus (4.9 ±
Table 3: Histopathology in brain regions of uninfected and infected mice
Mouse Meningitis PV Cuffing Inflammatory Lesions Calcifications Cysts Inflammation With Cysts
Co D H Ce Co D H Ce Co D H Ce Co D H Ce Co D H Ce
U 1 0 00 0 00 000 00 0 000 0 00 0 0 0
U 2 0 00 0 00 000 00 0 000 0 00 0 0 0
U 3 0 00 0 00 000 00 0 000 0 00 0 0 0
U 4 0 00 0 00 000 00 0 000 0 00 0 0 0
U 5 0 00 0 00 000 00 0 000 0 00 0 0 0
U 6 0 00 0 00 000 00 0 000 0 00 0 0 0
I 1 2 12 2 02 400 40 0 447 1 01 0 0 0
I 2 1 11 2 22 010 00 0 420 0 00 0 0 0
I 3 1 12 1 10 111 00 0 123 2 00 0 1 0
I 4 2 13 2 20 111 00 0 035 1 00 1 1 0
I 5 3 12 1 02 201 01 0 341 2 00 0 0 0
I 6 3 11 3 11 140 02 0 322 2 10 0 1 0
I 7 3 12 2 24 320 00 0 232 2 10 0 0 0
I 8 1 11 2 21 010 00 0 101 1 00 0 0 0
Abbreviations: U = uninfected, I = infected, U or I is followed by mouse number; Co = Cortex; D = Diencephalon; H = Hippocampus; Ce = 
Cerebellum
Scoring System: Meningitis scored 1 = mild; 2 = moderate; 3 = severe; PV cuffing 1 = mild; 2 = moderate; 3 = severe; Inflammatory Lesions 
scored according to number of lesions identified in one section; Calcifications Scored according to number of calcifications identified in one section; 
Cysts scored according to number of cysts identified in one section; Inflammation with cysts scored according to number of cysts adjacent to 
inflammatory lesion, by implication other cysts were 'sitting' in apparently normal brain.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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Inflammation in the brain during chronic Toxoplasma infection with only a few bradyzoites and cysts Figure 4
Inflammation in the brain during chronic Toxoplasma infection with only a few bradyzoites and cysts. (A) Occa-
sional cyst with bradyzoites a short distance from a vessel (arrow), × 250. (B) Medium power view showing perivascular cuff-
ing, × 100. (C) High power view of brain. Note perivascular cuffing and microglial infiltrates. Meningeal infiltrates also occurred 
(not shown), × 100. (D) Small numbers of microglial nodules (arrow) with diffuse inflammatory infiltrates throughout brain 
parenchyma, × 100. (E-I) Sections through the brains of chronically infected mice from the behavioral and neurologic studies, 
double labeled with rabbit anti-SAG1 visualised with anti-rabbit Ig conjugated to fluorescein isothiocyanate (green) and mouse 
anti-BAG1 visualised with anti-mouse Ig conjugated to Texas red (red). Bars represent 10 μm. (E, F) Examples of blood vessels 
(BV) cuffed with numerous inflammatory cells in which the plasma cells (P) can be identified by the cross reaction of the anti-
mouse Ig with the immunoglobulins within the plasma cell cytoplasm (red), × 400. (G) Low power of a nodule of inflammatory 
cells in which a few bradyzoites (red) but no tachyzoites (green) could be identified, × 100. (H) A section of brain showing a 
single tachyzoite (green) and tissue cyst (red) in an area with no inflammatory cells, × 100. (I) Detail from the enclosed area in 
G showing the cytoplasmic staining of the bradyzoites (Br) with anti-BAG1, × 1000.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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T cells and microglia in brains of chronically infected mice Figure 5
T cells and microglia in brains of chronically infected mice. Representative images of one of five infected mice. T lym-
phocytes were present in nodules and in the perivascular spaces in frontal cortex and diencephalons. CD4 T lymphocytes and 
microglia and CD8 T lymphocytes ×40. Immunohistochemical stains for CD11 indicate activated microglia. × 100. H & E stains 
also were performed. In contrast, preparations of brains from 5 uninfected mice revealed no inflammatory cells other than 
occasional microglial cells (not shown). Secondary antibody control stained tissues had no background staining (not shown).Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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2.4, 4.5, 3–10). The cerebellum showed less parenchymal
inflammation, but had perivascular inflammation and
calcifications (4.1 ± 1.1, 4, 3–6). The contrast in magni-
tude of pathology and cyst number in the specific regions
of the brain is shown in Table 3, 5. However, only some
of these differences (cyst number and calcifications)
reached statistical significance (p < 0.01 and p = 0.02,
respectively).
Prominent perihippocampal and hippocampal 
perivascular inflammation
There is an association of hippocampal abnormalities
with a number of neurological diseases of humans includ-
ing Alzheimer's disease, depression, and schizophrenia
[56-60]. Thus, it is especially noteworthy that in the
chronically infected mice there is an area of pronounced
inflammation in the leptomeninges contiguous to the
hippocampus, particularly around blood vessels (Figure
6). This was present in all of the eleven chronically
infected mice that survived to the end of the studies in the
second and the third replicate experiments. It was present
in those that had Magnetic Resonance Imaging (MRI), in
which tissues were available and this was specifically
examined. It was absent in all the thirteen uninfected con-
trols. This process was noted where the posterior cerebral
artery bifurcated (Figure 6 circled) and adjacent blood ves-
sels in the leptomeninges traversed the area next to the
hippocampus (Figure 6 arrows). The inflammation
extended along the blood vessels as they penetrated into
the hippocampus (Figure 6, hippocampus marked by
arrow). The inflammation was pronounced at the most
posterior part of this area but also accompanied vessels
continuing anteriorly to the areas above the third ventricle
and into the blood supply of the basal ganglia. (Figure 6
right panels provide detail of the pathologic process and
show the prominence of this peri-hippocampal process
and the absence of the process in the leptomeninges over-
lying the cortex in this micrograph.) The magnitude of the
Table 4: Comparisons (using Wilcoxon rank-sum test) of 
infected and uninfected mice
P-values Overall p-value*
PV Cuffing (co) 0.0003 0.0012
PV Cuffing (d) 0.0010
PV Cuffing (h) 0.0009
PV Cuffing (ce) 0.0090
Inflammatory lesions (co) 0.0096 0.0012
Inflammatory lesions (d) 0.0097
Inflammatory lesions (h) 0.0091
Inflammatory lesions (ce) 0.10
Calcifications (co) 0.39 0.0037
Calcifications (d) 0.20
Calcifications (h) -
Calcifications (ce) 0.0037
Cysts (co) 0.0035 0.0012
Cysts (d) 0.0037
Cysts (h) 0.0032
Cysts (ce) 0.20
Inflam w/cysts (co) 0.39 0.051
Inflam w/cysts (d) 0.39
Inflam w/cysts (h) 0.10
Inflam w/cysts (ce) -
n = 14; *Overall p-value after summing across the 4 brain regions.
Abbreviations: co = Cortex; d = Diencephalon; h = Hippocampus; 
ce = Cerebellum
Table 5: Comparisons of the four different brain regions for 
infected mice only
Co D H Ce p-value*
PV Cuffing 1 2 2 1.5 0.12
1-1 1–3 1–3 0–2
Inflammation 1.5 1 1 0 0.37
0–4 0–4 0–4 0–1
Calcifications 0 0 0 2.5 0.02
0–4 0–2 0-0 0–4
Cysts 2.5 2 1.5 0 < 0.01
0–4 0–7 0–2 0–1
Inflammation w/cysts 0 0 0 0 0.70
0–1 0–1 0–1 0-0
Overall** 4.5 6 4.5 4 0.61
2–12 1–13 3–10 3–6
Numbers in table are the median and range; n = 8; there were 
statistically significant differences in the four regions for calcifications 
and cysts; * From Friedman's test; **After summing across the 5 
findings.
Abbreviations: Co = Cortex; D = Diencephalon; H = Hippocampus; 
Ce = CerebellumJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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inflammatory process was comparable to other areas of
inflammation in the same mouse, but this region was uni-
formly involved in each of the eleven mice examined. This
more prominent inflammatory process is in the area of
the brain associated with short-term memory and spatial
orientation.
Neurologic findings and histopathology correlate
In the initial, first experiments in which very detailed
behavioral assessments were made, there also was a signif-
icant correlation between the degree of behavioral/neuro-
logical abnormalities and magnitude of the parasite
burden or inflammatory process (r = 0.87, 95% CI (0.59,
0.96), p = 0.0002; N = 6 infected and 6 uninfected control
mice). A correlation of behavioral and neurologic findings
with regions of histopathology is listed in Table 6. The
presence of calcifications, especially in the cerebellum,
without current inflammation suggested that there was an
earlier inflammatory process with necrosis that had
undergone dystrophic calcification. Lesions along the dis-
tribution of the motor pathway and the spinocerebellar
tract could also account for gait and tail abnormalities. In
the second and third replicate experiments, the infected
mice with the most abnormal gait had the most severe
brain inflammation and the smallest brains, and a mouse
with abnormalities of both legs had substantial inflam-
matory infiltrate in the corticospinal tract.
Prolonged treatment with sulfadiazine does not eliminate 
pathology
A separate group of similar SPF, chronically infected,
female SW mice were treated with sulfadiazine or left as
untreated, chronically infected, matched controls to better
understand whether conversion of bradyzoites egressing
from ruptured cysts into tachyzoites might elicit the
inflammatory response we observed. Sulfadiazine, which
is a competitive analogue of PABA and inhibits tachyzoite
growth, but not encysted bradyzoites, does not eliminate
all  T. gondii parasites from congenitally infected or
immune-compromised persons [90]. Sulfadiazine treat-
ment administered to our chronically infected mice for 4
months did not significantly modify pole balance (16.4 ±
12.9, range = 0–29 versus 23.6 ± 23.8, range = 2–60; p =
0.68) or grip test results (10.8 ± 5.4, range = 5–19 versus
9.6 ± 11.3, range = 1–29; p = 0.40) or the inflammation
and perivascular cuffing in the brain. Treatment with sul-
fadiazine did reduce, but did not eliminate, the number of
cysts (4.8 ± 0.8, range = 4–6 versus 8.0 ± 1.0, range = 7–9;
N = 5 mice per group, p < 0.01). These values are for
number of cysts in 50 microliters of half a brain, which
was homogenized and suspended in 2 ml. Thus, numbers
for the whole brain were these numbers of cysts multi-
plied by 80.
Heart and large vessels and levels of lipoproteins and 
inflammatory mediator SAA do not reflect a systemic 
inflammatory process
To better understand whether the inflammatory process
in brain was part of a systemic inflammatory process in
chronically infected mice, heart and large vessels, levels of
lipoproteins, and the inflammatory mediator SAA were
measured. There was no inflammation in the myocar-
dium, and atheromatous plaques were not present in
large vessels of mice that had the abnormal neurological
findings and brain histopathology (Table 3, 4) in the first
experiment (data not shown). Consistent with the
absence of this latter finding in our mice, plasma levels of
lipoproteins were not altered and assays for the inflamma-
tory mediator SAA from our chronically infected mice
showed that there was essentially no SAA in the plasma
Table 6: Correlations of region of brain involved and behavioral 
and neurologic findings
Co D H Ce
Grooming 0.52 0.62 0.78 0.54
Body Position 0.76 0.92 0.87 0.66
Piloerection 0.93 0.94 0.94 0.93
Tail Damage 0.84 0.71 0.74 0.89
Tremor 0.27 0.57 0.81 0.39
Palebral Closure 0.17 0.49 0.56 0.14
Lacrimation 0.42 0.57 0.57 0.30
Weight -0.23 -0.29 -0.28 -0.26
Spatial Locomotion -0.29 -0.41 -0.69 -0.45
Gait 0.42 0.56 0.38 0.28
Urination 0.93 0.94 0.94 0.93
Sniffs -0.78 -0.71 -0.53 -0.66
Rears -0.71 -0.56 -0.52 -0.72
Center -0.69 -0.45 -0.41 -0.71
Freezing 0.27 0.55 0.82 0.42
Latency to Move 0.67 0.44 0.35 0.66
Grip Strength -0.78 -0.57 -0.49 -0.76
Pain Insensitivity 0.64 0.65 0.72 0.67
Bolded, italicized numbers indicate statistical significance (p < 0.01).
Abbreviations: Co = Cortex; D = Diencephalon; H = Hippocampus; 
Ce = CerebellumJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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Perivascular inflammatory infiltrates in vessels that supply the hippocampus (circle) adjacent to the hippocampus (labeled H)  and in vessels contiguous to and in the hippocampus (arrows) and at the base of the brain Figure 6
Perivascular inflammatory infiltrates in vessels that supply the hippocampus (circle) adjacent to the hippocam-
pus (labeled H) and in vessels contiguous to and in the hippocampus (arrows) and at the base of the brain. No 
such inflammatory cells are seen in uninfected control mice.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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samples from either control or chronically infected mice
(data not shown).
Effect of antibody to PD-1L on amount of inflammatory 
infiltrate and number of cysts
Because there was increased expression of PD-1L in whole
genome microarrays, and this is a ligand that allows per-
sistent Lymphochoriomeningitis virus brain infection by lim-
iting activity of T cells, hamster antibody to PD-1L or
isotype-control was administered every 7 days for 21 days.
There were three mice tested in each of the following
groups: no antibody, isotype-control antibody, and anti-
body to the PD-1L ligand. Hamster antibody to PD-1L,
which has been demonstrated in other studies to abrogate
murine PD-1L function, did not significantly decrease the
number of cysts (p = 0.12). The median number of cysts
were 13, 6, and 5 in the no antibody, isotype-control anti-
body, and PD-1L antibody groups, respectively. Addition-
ally, inflammation was present in all the groups (p =
0.56). In the mice that received the anti-PD-1L there
appeared to be an increased amount of inflammatory
infiltrate relative to the numbers of cysts.
Administration of isolated parasites produces the same 
pathology
To address whether infection with concomitant patho-
gens or parasites administered together with inoculation
of brain tissue caused the brain pathology, histopathology
of brain from SPF mice chronically infected with Me49
strain (clonal type II) parasites, inoculated without brain
tissue, was also studied. The pathology in these mice
infected with bradyzoites from isolated cysts (Figure 7A–
C) was similar to that described above.
Genetically resistant BALB/c mice also have perivascular 
and leptomeningeal inflammation, but there is much less
To determine whether a genetically resistant strain of
mouse would have the same type of pathology when
chronically infected, chronic infection of BALB/c mice, a
strain that is genetically resistant to acute infection and
(A-C) Similar histopathology with perivascular inflammation, isolated cyst ×40, and cluster of microglia in a mouse that is  chronically infected, initially infected with parasites without accompanying brain Figure 7
(A-C) Similar histopathology with perivascular inflammation, isolated cyst ×40, and cluster of microglia in a 
mouse that is chronically infected, initially infected with parasites without accompanying brain. A ×40; B ×250; C 
×20. (D) Less prominent perivascular cuffing (circle) and small collections of mononuclear cells in Balb/C mouse that is geneti-
cally more resistant. E. Increased magnification of area of perivascular inflammation. × 100.(F) Perivascular inflammation × 40 
for mouse that had mild lateral ventricular dilatation in MRI.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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toxoplasmic encephalitis, was also studied. In SPF BALB/c
mice infected with clonal type II Me49 parasites for 6
months (N = 5 infected, 3 controls), there were only very
rare cysts seen but there was a small amount of perivascu-
lar accumulation of inflammatory cells in 4 of the 5
infected mice and leptomeningeal inflammation that was
not seen in the controls. These results were similar to stud-
ies of brains of BALB/c mice infected for 60 days. Figure
7D is a representative example of this pathology figure 7E
is a higher power view of this area of brain. All analyses of
tissues of these mice were performed by a pathologist
without knowledge of the infection status of the mice
from which the tissue was derived.
Subacute infection in mice with knockout of IL-4, IL-6, IL-
13 or NRAMP elicits the same brain histopathology
Because IL-4, IL-6, IL-13 and NRAMP are very important
in immunity to toxoplasmosis and could play a patho-
genic role in the inflammatory process we observed, mice
without IL-4, IL-6, IL-13, or Nramp, infected for shorter
times, were also studied to determine whether these
cytokines or immune processes were necessary and suffi-
cient for the perivascular cuffing and meningeal and
parenchymal abnormalities we had observed. These mice
also had prominent perivascular cuffing and parenchymal
infiltrates, in a distribution similar to that in the outbred
mice (FR, CWR, data not shown) indicating that these
cytokines and NRAMP were neither necessary nor suffi-
cient to cause the pathology we observed.
Brain histopathology of mice that had MRIs
To determine whether the type of histopathology we
observed would be reflected in a conventional MRI,
immediately following the MRIs the brain was removed
and fixed in formalin for subsequent histopathologic
analysis. The histopathological changes in brain were sim-
ilar to those described above for the infected mice show-
ing mild to moderate parenchymal inflammation,
perivascular cuffing with inflammatory cells, and lep-
tomeningeal inflammation with scattered cysts without
inflammation. The uninfected age-matched controls
housed in the same colony for 13 months had no brain
pathology (p = 0.02 for comparison to infected mice). Fig-
ure 4A–D shows the brain histopathology of a represent-
ative mouse with only slight ventricular dilatation.
Electron microscopy and immunostaining of the intact and 
ruptured tissue cysts
The intact cysts were located in neurons identified by the
presence of synapses between the host neuron and adja-
cent neurons (Figure 8A–C). On extremely rare occasions
it was possible to observe tissue cyst rupture, which was
associated with loss of the host cell (Figure 8D, inset). It
was found that mononuclear cells were surrounding the
cyst and invading through the ruptured cyst wall. The
monocytes were attacking and engulfing the bradyzoites
(Figure 8D). The bradyzoites were destroyed before they
could convert to tachyzoites.
Discussion
Neurologic and behavioral abnormalities in chronically 
infected mice that acquired primary infection in early 
adulthood are progressive and persistent
Herein we found that chronic T. gondii infection of SPF
SW mice following infection in early adulthood alters
their appearance, behavior and neurological function,
including autonomic function, pain sensation, motor
function, balance, spatial, grip strength, coordination,
and lack of pain sensation. Many of these findings have
not been reported in rodent models before. The abnor-
malities are clearly more prominent in the SPF SW mice
than only alterations in fear, i.e., lack of fear when smell-
ing cat urine ascribed to the amygdala in Balb/c mice by
Vyas et al [15] and substantially more global than the sub-
tle, poorer grooming, and decreased exploratory behavior
described earlier by others such as Hutchinson [7] and
Hay et al [8]. Hutchinson [7] and Hay [8] also described
increased movement by chronically infected mice which
was not observed in this study. In contrast to only a few
specific abnormalities, the global sensorimotor loss is
present in the months following infection, is progressive,
and persists a year or more after infection. Others with
colonies of chronically infected mice, some convention-
ally housed and some SPF, also observed, but did not
report, similar findings (e.g., Louis M. Weiss, M.D., M.Ph.,
Albert Einstein College of Medicine, Bronx, NY, Jack S.
Remington M.D., Stanford University and Palo Alto Med-
ical Research Institute, Palo Alto, California, personal
communications to RM, 2006).
Conventional neuroimaging (MRIs) of chronically infected 
mice provides insight into identification of consequences 
of chronic T. gondii infection
Brain MRIs are an initial step in evaluating neurologic and
behavioral abnormalities in patients that are similar to
those we observed in our chronically infected mice. There-
fore, findings in brain MRIs of chronically infected mice
were of interest. Brain MRIs were performed with DBA
mice chronically infected for 8 months and were not per-
formed with the SW mice with the detailed analysis of
behavior and neurologic abnormalities because of logisti-
cal constraints. Neurologic abnormalities similar to those
in the SW mice also were observed in the chronically
infected DBA mice that were imaged (L. Weiss, personal
communication, 2006) although they were not quanti-
tated systematically as was done for the SW mice. Histopa-
thology of both the SW and DBA mice (Figures 4, 6, and
7) were subsequently compared and also found to be sim-
ilar.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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With the marked neurologic and behavioral findings that
we and others (on further analysis) had noted in chroni-
cally infected mice, we expected to find a pathology in
brain MRIs during chronic infection that would be
reflected in enhancing lesions or areas of necrosis or other
discrete pathology in the brain MRIs. Interestingly, and
surprisingly, standard non-invasive, objective, imaging
measures of brain parenchyma such as standard brain
MRIs of mice infected with T. gondii for 8 months, with
similar histopathology to those mice that had extensive
behavioral and neurologic testing, demonstrated only and
primarily ventricular enlargement, particularly along the
aqueduct of Sylvius, and asymmetry in contrast uptake in
T2 weighted scans of infected mice. It seemed remarkable
to have profound, repeated, and consistent behavioral/
neurological findings without an obvious inflammatory,
necrotic or other pathologic changes reflected in the MRI.
The areas in which abnormalities were most prominent in
the periaqueductal and periventricular areas are areas that
have been noted to be abnormal in some congenitally
infected persons, but have not been noted to be preferen-
tially affected in adult acute acquired infections. Interest-
ingly, in congenitally infected infants and in murine
(A-B) Details of the periphery of tissue cysts from chronically infected mice identifying the host cells (HC) as neurons due to  the formation of synapses (arrows) Figure 8
(A-B) Details of the periphery of tissue cysts from chronically infected mice identifying the host cells (HC) as 
neurons due to the formation of synapses (arrows). Based on the structure of the synapse the cysts appear to be within 
a neuronal dendrite. V – neurosecretory vescicles; CW – cyst wall; Br – bradyzoite. Bars represent 100 nm. (C) Low power of 
a cyst containing numerous bradyzoites (Br) within a host cell (HC). Note the absence of inflammatory cells. Bar is 1 μm. (D) 
Low power of a ruptured tissue cyst showing numerous inflammatory cells (M) around and invading through breaks in the cyst 
wall into the tissue cyst. Bar is 10 μm. Inset: Similar area to that in D immunostained with an antibody to the cyst wall (CC2) 
showing the disruption to the tissue cyst wall (arrows) and the surrounding inflammatory cells. Bar is 10 μm. (E) Detail from D 
showing bradyzoites (Br) that had been phagocytised by inflammatory cells. Bar is 1 μm.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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models, periaqueductal inflammation leads to hydro-
cephalous.
It is of interest that expression of the ABCA4 gene is local-
ized to the periventricular/perihippocampal area (Figure
9) and that this same area is noted to be prominently
involved in the MRIs (Figure 3) and histopathology (Fig-
ure 6) of the chronically infected mice. We (RM) recently
noted that ABCA4, which transports toxic oxidized lipids
out of cells, has a susceptibility allele associated with
development of hydrocephalus in human congenital tox-
oplasmosis [39]. This association has a parent of origin
inheritance pattern and thus the allele of this gene which
is expressed is imprinted in utero (i.e., epigenetically mod-
ified). Other genes important in pathogenesis of T. gondii
infection also are expressed in this area of the brain (Fig-
ure 9) including VCAM and ICAM. T. gondii microneme
protein 2 (MIC2) binds to VCAM and is important in par-
asite attachment during invasion of cells. These findings
taken together, suggest that T. gondii may secrete mole-
cules with the capacity to epigenetically modify expres-
sion of genes important in neurodevelopment or death of
infected neurons, or cause bystander cell death, or modify
immune responses especially in the area of the brain con-
tiguous to the aqueduct, ventricles and hippocampus [91-
93].
Recently developed imaging techniques might, in the
future, provide additional, useful insights; e.g. vasculitic
changes that may go undetected in standard MRIs may be
detected with FLAIR images. Use of functional MRIs and
imaging of stem cells with differences in lipids to identify
functions of specific regions in human brains [94] and
volumetric MRIs to assess hippocampal size and size of
other brain regions might be useful and informative in
future studies. Ventricular dilatation we observed in MRIs
of chronically infected mice, compared with uninfected
mice, described herein suggests that there is neuronal cell
loss or damage. In similar standard MRIs in persons with
neurodegenerative disease affecting the hippocampus,
loss of brain parenchyma in the medial aspects of the tem-
poral lobes is manifested by similar increases in lateral
ventricular volume.
Neurologic and behavioral abnormalities correlate with 
lower brain weight and inflammation, especially in 
perihippocampal, hippocampal, and periventricular areas, 
in histopathologic studies of brain of SW mice
To better understand pathology and pathogenesis of the
behavioral and neurologic findings we observed, brain
weights were correlated with magnitude of neurologic
abnormalities. We found that magnitude of the abnormal
neurologic findings correlated with lower brain weight.
There were no abnormal neurologic findings in unin-
fected controls. This loss of brain parenchyma among
infected mice is consistent with the dilated ventricles seen
in the MRIs.
The histopathologic findings observed included individ-
ual cysts with no surrounding inflammation remote from
perivascular collections of plasma cells, CD4+ and CD8+
T cells and microglial cells, and parenchymal and lep-
tomenigeal collections of T cells and microglia. Peri-hip-
pocampal, hippocampal perivascular and leptomeningeal
inflammation were especially prominent (Figure 6). The
locations in brain of these collections of cells correlated
with and provide an understanding of the anatomic sub-
strate of the specific and broad array of behavioral and
neurologic findings (Figure 1 and 2, on-line movie (Addi-
tional file 1), Table 1) noted. Mice with the most inflam-
mation had the smallest brains and most abnormal
neurologic and behavioral findings. Mice were infected
with 100 cysts, a relatively large dose. Since parasite bur-
den seemed to correlate with the severity of disease, it is
possible that a lower inocula might better simulate the
subclinical outcome representative of natural infections
in those who are genetically resistant.
Histopathology provided additional initial insights into
pathogenesis of the neurologic findings. Microglial cells, a
prominent part of the histopathology we and others
[8,50,95] observed in chronically infected mice, also are a
feature of neurodegenerative diseases, including Alzhe-
imer's disease, multiple sclerosis, Parkinson's disease,
AIDS dementia, and stroke. In these diseases and models
for them, microglial cells have been reported to produce
neurotoxic molecules, e.g., nitrous oxide, proinflamma-
tory cytokines, particularly TNFα and IL-1β, and reactive
oxygen species [96,97] which can cause neuronal cell loss.
Recent studies have indicated that mitogen-activated pro-
tein kinases mediate glia-induced neuron death [98]. T.
gondii dense granule protein 10 (GRA10) has been noted
to modulate host TAF1 and p38 MAPkinase [99]. The
inflammatory infiltrates observed in our murine model of
chronic T. gondii- induced encephalitis suggest that micro-
glia may affect both infected host neurons and by-stander
neurons. Van Eldick et al. have demonstrated that inflam-
matory mediators also modify clearance of misfolded pro-
teins [98]. Recently, such inflammation has been found to
augment prion diseases [55,100].
Similarly, persistent perivascular inflammation, especially
involving glial cells [101], is common to a number of neu-
rodegenerative diseases including Multiple Sclerosis,
Alzheimer's Disease, Rasmussen's syndrome, Bin-
swanger's disease and subacute sclerosing pancephalitis.
In a recent study in mice, perivascular cuffing in the hip-
pocampus increased the normal distance between neural
progenitor cells and the vasculature in mice; this increased
distance was associated with accelerated rates of cognitiveJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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ABCA4, VCAM and ICAM are expressed in the perihippocampal, hippocampal and periventricular areas Figure 9
ABCA4, VCAM and ICAM are expressed in the perihippocampal, hippocampal and periventricular areas. 
Images obtained from the Allen Brain Atlas.Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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decline in mice [101]. The pronounced perivascular
inflammatory process contiguous to the hippocampus
seen in all 11 mice from the 3 different experiments where
this was specifically examined, suggests that this area of
the brain in mice has pronounced pathology. It is of inter-
est that it is the hippocampus which is involved early in
Alzheimer's disease, is of smaller volume in schizophrenic
patients and those with depression [57-60,102] and is an
area of the brain in which its activity in fMRIs is associated
with optimism [61].
Special stains did not add insight into pathogenesis with
positive findings but rather indicated that in this murine
model of chronic toxoplasmosis that there is not demon-
stratable, extensive focal demyelination, axonal loss or
amyloid precursor protein contributing to the pathology.
Immunostaining for tachyzoites and bradyzoites and 
review of electronmicrographs provides insights into 
initiation of the inflammatory process
With immunostaining for tachyzoites and bradyzoites, we
noted an absence of tachyzoites and only rare free
bradyzoites present with inflammatory lesions in the
brains of the same mice studied for behavioral, neuro-
logic, conventional histopathology and microarrays
where inflammatory processes were noted. These immu-
nostaining results are replicated in other work described
previously [50,51]. In the histopathologic sections, it is
noteworthy that the individual cysts were usually remote
from the inflammatory process.
Electron micrographs made with brains from convention-
ally housed, chronically infected, outbred mice have been
reported earlier [50,51,103,104] and new images
included herein as Figure 8 provide additional insights
concerning pathogenesis when placed in the context of
the other findings presented herein. In these electron
micrographs, T. gondii cysts occupied much of the cyto-
plasm of neuronal cells and the neurons formed synapses
(Figure 8A, B), indicating that they are capable of some
differentiated functions even with large cysts inside them,
although the functioning of such synapses has not been
studied. No inflammatory process is noted around the
perimeter of the individual cyst when the neuronal mem-
brane was intact.
An earlier study of T. gondii in the brains of chronically
infected mice, noted that only 2 of ~750 cysts were out-
side intact host cells [50]. In the rare circumstances when
neuronal cell membranes were not present around intact
cysts or cysts that had ruptured, there was a marked inva-
sion of inflammatory cells, predominately mononuclear
cells but also neutrophils (Figure 8C–E). In our outbred
SPF mice chronically infected with T. gondii described
under histopathology and transcriptome (please see 4.3
and 4.4), immunostaining of brain tissue demonstrated
that CD4+ and CD8+ T cells, B cells, and microglia
(CD11+) were present in similar areas of parenchymal
inflammation and perivascular cuffing (Figure 5). This
inflammation occurred whereas brains from uninfected
control mice had no inflammatory process. Staining for
mouse immunoglobulin shows that antibody-secreting
cells are present in the perivascular cellular infiltrates and
this and their morphology indicate that these are plasma
cells (Figure 4E) and confirmed by electron microscopy
[51]. Although the cysts in brains of chronically infected
SPF mice have no surrounding inflammation (Figure 1;
Table 3) the electronmicrographs in which bradyzoites are
associated with inflammatory cells and clearly elicit an
immune response, suggest that they may be the life-cycle
stage of the organism that causes this immune response
once they are outside neurons. This occurs without the
need to have bradyzoites convert to the tachyzoite life-
cycle stage, which has been demonstrated to cause pathol-
ogy in immune compromised mice and humans [38,82].
The occasional large cysts that contained parasites within
neurons elicit no inflammatory response, although others
and we have found that Toxoplasma antigens are present in
cyst walls (Figure 8D, inset). Whether the neurons con-
taining these large cysts function entirely normally is
unknown but they do form synapses [51,103-105].
These collective findings support the following hypothe-
sis: Bradyzoites from cysts in neuronal cells in which host
cell membrane is intact elicit no inflammatory response.
When the neuronal membranes are disrupted,
bradyzoites are ingested by mononuclear cells and these
bradyzoites elicit the initial inflammatory response. Then,
as described by Van Eldick et al [98], neuronal damage
may be associated with cytokines or chemokines from
such cells that are known to elicit neurologic damage and
loss as a bystander effect in other diseases.
Transcriptomes of brain from chronically infected SW mice 
compared with uninfected mice provide additional insights 
into the molecular pathogenesis of behavioral and 
neurologic abnormalities and histopathology
Herein, we note that a variety of inflammatory responses
and neuronal cell death are reflected in transcriptomes of
brains (Table 2) from the chronically infected mice that
had behavioral and neurologic testing and histopatho-
logic study. Microarray analysis of gene expression of
chronically infected brain tissue and uninfected control
brain tissue is consonant with the histological observation
that lymphocytes, particularly B cells and antibody secret-
ing plasma cells, are present in the perivascular cuffing.
The microarray results showed 326 probes (correspond-
ing to 311 different genes) with a posterior log odds of dif-
ferential gene expression greater than 2 (i.e. a posterior
probability greater than 0.88) and an adjusted P-value lessJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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than 0.01. Surprisingly, all these genes showed greater
expression in the chronically infected brains and many are
associated with the immune response (Table 2). This sug-
gests that the majority of differential expression is proba-
bly due to the presence or greater abundance of particular
cell types rather than a change in regulation of the cells
normally resident in the area.
Expression of chemoattractants Ccl5 and Ccl8, which pro-
mote monocyte and lymphocyte recruitment [106,107], is
consistent with the presence of B cells and the dominance
of immunoglobulin genes and the perivascular and brain
parenchymal inflammatory process. Heavy and light
(both kappa and lambda) chain genes comprise two
thirds of the list (since cross-hybridization may occur on
the array, classification of the variable region family/type
is not possible). Consistent with this is the support of B
cell growth and lymphocyte activation by Bst2 and Lag3
respectively [106,108]. The increase in PD-L1 (CD274)
ligand, associated with "exhausted" T-cells in a chronic
viral infection [86,109], may be a contributing factor that
allows latency in chronic Toxoplasma infection, although
other molecules may also play a role [110]. PD1L has
recently been found to tolerize T cells in the brain in acute
toxoplasmosis (I. Kahn unpublished data, personal com-
munication to R. McLeod, July 2008) which makes the
observation of its increased expression in the brain in
chronic murine toxoplasmosis noted herein especially
interesting and important. Increased expression of PD-1L
suggests that the inflammatory cells that are attracted into
the brain may not always be fully functional effector T
cells, as demonstrated in LCMV infection [86,109] when
this is associated with diminished activity of T cells.
Greater expression of MHC class I, class II and proteo-
some related genes indicates an increase in antigen
processing and presentation. IFN inducible GTPases of
both the p47 and p65 classes are consistent with anti-
microbial and, perhaps even more specifically, anti-intra-
cellular pathogen activity. IGTP has been shown to be
important in limiting T. gondii growth in astrocytes [111].
This induction is dependent upon STAT1 for expression
[112], a transcription factor that is increased in our study.
Counterbalancing the IFN/inflammation is the increase in
the cyclophilin associated protein scavenger receptor
Lgals3b [113]. The increase in CD36 may be relevant to the
pathogenesis of behavioral abnormalities and pathology
given its role in other conditions including cerebral
malaria and Alzheimer's disease [114,115]. CD 36 inter-
acts with TOLL receptors 2/4 with glycoplipid ligands elic-
iting innate immune responses and influences
susceptibility to cerebral malaria and dendritic cell func-
tions [116]. The increase in Gfap is consistent with astro-
cyte response to neuronal cell damage [117].
In addition to the above genes mentioned, the mRNA for
subunits of C1q is found in greater abundance compared
to the controls, raising the possibility of neuronal loss
directly through complement expression and tagging. Pre-
vious studies have shown that complement component
C1q is upregulated in a range of neurodegenerative dis-
eases including Alzheimer's disease (see for example Fon-
seca et al [118]). Recent evidence in a mouse model
suggests that in the normal development of neural cir-
cuits, C1q "tags" inappropriate synaptic connections for
selective elimination [119]. Signaling from immature
astrocytes appears to induce C1q expression in microglia
and neurons and it was hypothesized that reactive astro-
cytes seen in brain injury may provide a similar signal,
ultimately leading to synapse loss and neuronal death.
The regulation of complement appears to be balanced as
the slp increase suggests the need for immune complex
clearance concomitant with a Serping1 increase, inhibiting
complement activation via the classical pathway.
Interestingly, neuronal signaling and brain development
pathways recently identified as disrupted with rare struc-
tural variants in a genetic analysis of persons with schizo-
phrenia included signal transduction, neuronal activities,
nitric oxide signaling, synaptic long-term potentiation,
glutamate receptor, ERK/MAPK, phosphatase, axonal
guidance, G protein receptor, signaling integrin, and
Sonic hedgehog [120]. These mechanistic molecular proc-
esses certainly have the potential to be modulated by T.
gondii or inflammation it elicits as identified in our full
genome arrays.
Collectively, these data present a developing picture of the
behavioral/neurodegenerative effects of chronic T. gondii
infection. Clearly this is a dynamic situation and a time
series study, combined with the determination of which
cells are contributing to the expression increases for a
given gene, will be of considerable interest.
Additional studies of pathogenesis
T. gondii, and not adventitious pathogens, or concomitant
administration of brain tissue, caused the meningoen-
cephalitis since it was present in SPF mice administered
parasites alone. The observation that this meningoen-
cephalitis could be only partially abrogated with sulfadi-
azine treatment suggests that cyst rupture exposing
bradyzoites sequestered from sulfadiazine in cysts, rather
than bradyzoite to tachyzoite transformation and tach-
yzoite growth, might be a primary stimulus for inflamma-
tory processes.
Small collections of perivascular and meningeal inflam-
matory cells also were observed even in chronically
infected, genetically resistant, inbred SPF mice [85]. Inter-
estingly, in a recent report, genetically resistant BALB/cJournal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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mice infected a month, a time cysts were predominant
and tachyzoites were not present, also had a more specific
and anatomically localized behavioral abnormality [15].
The presence of the same pathology in mice without
NRAMP, IL-4, IL-6, or IL-13, each important in immunity
to toxoplasmosis [40], indicates that none of these genes
or cytokines are necessary or sufficient to cause this his-
topathology.
Absence of inflammation outside the central nervous sys-
tem suggests that behavioral abnormalities and neural
lesions probably are not caused by a concomitant, periph-
eral, inflammatory process. Gazzinelli et al. reported that
adult apo E deficient mice previously infected with T. gon-
dii in young adulthood (puberty) developed much more
(and more severe) atheromatous disease [121]. Our
model differs because our mice are apo E sufficient and
therefore develop much less atheromatous disease.
What are the insights from and limitations of murine 
models in providing a basis for generating hypotheses 
about how chronic T. gondii infection might affect the 
brain of humans? What is known about T. gondii infection 
of the brain in immune competent persons?
Although there are no data from humans in the work
described herein, these data from mice raise questions as
to whether inflammation in brain caused by T. gondii
infection could act as a co-factor in the development of
neurodegenerative diseases in some genetically suscepti-
ble individuals. These data provide insights into regions
of the brain most affected which parallel findings in
humans [54]. T. gondii cysts are seen occasionally in brain
from immunologically normal persons at autopsy (FR,
unpublished), without any contiguous inflammation,
which is much like observations of mice in this study,
especially those mouse strains that are genetically more
resistant (Figure 7D). The findings in mice of chronic
inflammation without visible free tachyzoites and very
rare extracellular bradyzoites, which share similarities to
responses in neurodegenerative diseases in humans, raise
questions as to whether inflammation associated with
chronic, cryptic T. gondii infection might cause low grade
encephalitis or function as a co-factor in common neuro-
degenerative or other neurologic diseases in some geneti-
cally susceptible individuals and extracellular parasites
might not be visible. Genetics has a profound influence
on susceptibility to acute, subacute and congenital mani-
festations in this infection both in experimental animals
and in humans [33,34,38,39,122,123].
Central nervous system toxoplasmosis in apparently
immunologically normal persons has been reported only
rarely [124,125]. Toxoplasmic meningo-encephalitis and
chronic T. gondii antibody production in cerebrospinal
fluid of persons with chronic neurologic diseases without
known immune-compromise have been reported
[124,125], but these findings are not thought to occur
commonly. In toxoplasmic encephalitis, which is more
frequently but not exclusively reported in immune-com-
promised individuals, findings are often focal and reflect
large areas of necrosis [124] due to unconstrained
bradyzoite to tachyzoite switch and then the replication of
tachyzoites not contained by a competent immune
response leading to encephalitis or necrosis. An inflam-
matory process resulting in extensive necrosis and prolif-
eration of tachyzoites has been described in some mouse
models of infection, e.g., in C57BL/6J mice, but not in
immunologically normal SPF outbred mice. Although
inflammation around blood vessels and in brain paren-
chyma has been described in outbred mice infected with
some but not all isolates of T. gondii earlier [37], this has
not previously been well-characterized as to precise loca-
tion in the brain, extent of inflammation, whether there
are directly linked consequences on behavior, or the
cause. To our knowledge, many of these findings we noted
have not been recognized in other animal models. They
certainly are consistent with findings associated with
other chronic encephalitidies and neurodegenerative dis-
eases but for the most part they have not been ascribed to
chronic toxoplasmosis. There are many cases of encepha-
litis of unknown etiology [126] but whether and if so how
often  T. gondii might cause chronic encephalitis in
humans or non-human animals during chronic infection
is not known.
The prominent peri-hippocampal and hippocampal
perivascular leptomineageal process in the mice we stud-
ied also is of interest because of the association of hippoc-
ampal abnormalities in neurodegenerative diseases,
depression, and schizophrenia [60]. In schizophrenia
there are epigenetic modifications of human DNA [49]
that are reminiscent of the manner in which T. gondii
modifies HERVS in a human neuronal cell line [48]. In
Aicardi-Goutieres's Syndrome, there are calcifications in
these same areas of brain, e.g., basal ganglia and periven-
tricular areas, that mimic this congenital infection [127].
The recent finding that Aicardi-Goutieres's Syndrome is
caused by mutations in a DNAase, TREX1, which leads to
increased interferon-α production [128], suggests a possi-
ble similarity in pathogenesis of Aicardi-Goutieres's syn-
drome abnormalities and some of those in human
congenital toxoplasmosis. Also the occurrence of calcifica-
tion in congenital toxoplasmosis in basal ganglia and
localization of T. gondii recrudescence in dopaminergic
areas, e.g., the basal ganglia, in immunocompromised
persons suggests that there may be a predilection for the
parasite to infect these areas in humans [1,90,124]. The
hippocampus contains dopaminergic neurons. The prom-
inent involvement of the area around the aqueduct of Syl-Journal of Neuroinflammation 2008, 5:48 http://www.jneuroinflammation.com/content/5/1/48
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vius remains unexplained and is of interest in this context.
Further, the increased expression of PD-1 ligand and
CD36 raise the provocative questions about whether T.
gondii shares mechanisms to down-modulate critical pro-
tective immune functions that also allow latency in infec-
tions with certain viruses or cause pro-inflammation
contributing to neurodegeneration. The increased expres-
sion of C1q raises questions about neuronal synapse
remodeling or bystander cell death. The full genome
microarrays in the context of our other studies provides
insight into gross, cellular, subcellular and molecular
pathogenesis and consequences of CNS toxoplasmosis in
mice. In so doing, this work provides a foundation for
hypotheses for studies to determine whether, and if so
where and how T. gondii might cause similar changes in
the brain of some humans.
Our findings, their putative pathogenic mechanisms, and
consequences for neuronal cells, based on our observa-
tions herein as well as observations of others, are summa-
rized in Figure 10. These potential pathogenic
mechanisms depicted, might include usurping or interfer-
ing with functions of neurons infected by T. gondii
bradyzoites within large cysts. The presence of bradyzoites
in large cysts within synapse forming neurons has been
described [101,102], but whether such synapses function
normally or whether the cysts could affect neuronal func-
tion is not known. Parasites within neurons could directly
result in death of infected neurons or there could be death
of contiguous bystander neurons. If low-level inflamma-
tion was primed and maintained by the chronic infection,
NO and toxic oxidized lipids or other toxic oxygen prod-
ucts could contribute to bystander cell death. Additional
molecular mechanisms causing behavioral and neuro-
logic findings in mice remain to be determined and char-
acterized more fully. It will be of interest to determine
whether some or all of these processes occur in genetically
susceptible persons.
Conclusion
In outbred mice, chronic T. gondii infection of a year or
more duration following primary infection in early adult
life causes behavioral and neurologic abnormalities and
ventricular dilatation in MRIs of the brain. This reflects
loss of brain parenchyma and inflammation that is partic-
ularly prominent in and contiguous to the hippocampus
and around the aqueduct of Sylvius and third ventricle.
There is also increased expression of message for media-
tors of inflammation and synaptic remodeling and mark-
ers of neuronal cell death in brains of chronically infected
mice, not present in uninfected control mice. Bradyzoites
may cause the inflammation when there is no neuronal
membrane around cysts, which usually are sequestered in
neurons. Then, these bradyzoites are engulfed by mono-
nuclear cells leaving only rare visible free bradyzoites and
virtually no free tachyzoites. These observations suggest
that the ongoing inflammatory process effectively elimi-
nates parasites outside cysts in neurons but in the process
may destroy brain parenchyma. Brain weight correlates
with magnitude of neurologic and behavioral abnormali-
ties and histopathology in specific regions of the brain
(including collections of plasma cells secreting antibody,
T lymphocytes, macrophages in perivascular areas, micro-
glial cells, and lymphocytes in brain parenchyma) pro-
vides the anatomic basis for the correlations. Genetic
background of the host profoundly influences this proc-
ess, but even in the most resistant mouse strain there is
still a small amount of perivascular inflammation. Defi-
ciency in IL4, IL13 and NRAMP are not sufficient to abro-
gate this inflammatory process. Microarrays provide
insight into the molecular pathogenesis of the processes
in the outbred mice reflecting inflammation, attenuation
of this inflammation by counter regulatory processes,
neuronal cell death and potential remodeling of synapses
with increased expression of C1q, as well as CD36, immu-
noglobin genes, GFAP, and PD-1L in these transcrip-
tomes. The implications, if any, of our findings in mice for
human diseases and this very common chronic brain
infection of humans remain to be determined. This
mouse model of chronic T. gondii infection raises ques-
tions of whether persistence of this parasite in brain can
cause inflammation or neurodegeneration, particularly
contiguous to and in the hippocampus, periacqueductal
and periventricular areas, in genetically susceptible
humans.
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Schematic summary of cells, molecules, and processes affected by chronic T. gondii infection resulting in neuronal cell loss,  inflammation, and behavioral and other neurologic abnormalities in mice Figure 10
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